MX2007012758A - Cyano anthranilamide insecticides. - Google Patents

Abstract

Compounds of formula (I) wherein the substituents are as defined in claim 1 , and the agrochemically acceptable salts and all stereoisomers and tautomeric forms of the compounds of formula I can be used as agrochemical active ingredients and can be prepared in a manner known per se.

Description

INSECTICIDES OF CIANO ANTRANILAMID & FIELD OF THE INVENTION The present invention relates to new anthranilamide derivatives, to processes for their preparation, to compositions comprising said compounds, and to their use to control insects or representatives of the order Acariña.

BACKGROUND OF THE INVENTION Anthranilamide derivatives with insecticidal properties are known and described, for example, in WO 04/067528. They have now been found in new derivatives of cyano-substituted anthranilamides with pesticidal properties, especially for the control of insects and elements of the order Acariña.

BRIEF DESCRIPTION OF THE INVENTION The present invention therefore relates to compounds of formula I REF. : 186629 where each of E and Z, which may be the same or different, represents oxygen or ur; A is Ci-Ce alkylene, C2-C6 alkenylene, C2-C6 alkynylene, or a fused monocyclic or bicyclic bicyclic ring system of three to ten elements which may be partially saturated or fully saturated and which may contain 1 to 4 heteroatoms selected from group formed by nitrogen, oxygen and ur, where it is not possible for each ring system to contain more than 2 oxygen atoms and more than 2 ur atoms; and it is possible that the ring system of three to ten elements and also the alkylene groups Ci-Ce, C2-C6 alkenylene and C2-Ce alkynylene are mono-, di- or trisubstituted with halogen, cyano, nitro, hydroxy, Ci-alkyl -Cß, C2-C6 alkenyl, C2-C6 alkynyl, C3-Cd cycloalkyl, C5-C cycloalkenyl, C5-C8 cycloalkynyl, Ci-Cß haloalkyl, C2-C6 haloalkenyl, C2-C6 haloalkynyl, C3- haloalkylalkyl, C5 haloalkylalkenyl -C7, C5-Ce haloalkylCalkyl, C? -C4 alkoxy, C? -C4 haloalkoxy, C? -C alkylthio, C? -C4 haloalkylthio, C? -C4 alkylinyl, C? -Calkylonyl, C? -C4 alkylamino, C2-C4 dialkylamino, C3-C6 cycloalkylamino, Ci-C3-cycloalkylamino C3-C6 alkyl, C2- /? alkylcarbonyl? , C2-C6 alkoxycarbonyl, C2-C6 alkylaminocarbonyl, C3-C6 dialkylaminocarbonyl, C2-C6 alkoxycarbonyloxy, C2-C6 alkylaminocarbonyloxy, C3-C6 dialkylaminocarbonyloxy or trialkylsilyl C-C, or by a monocyclic or bicyclic ring system fused from three to ten elements that can be aromatic, partially saturated or fully saturated and can contain 1 to 4 heteroatoms selected from the group consisting of nitrogen, oxygen and ur, where it is not possible for each ring system to contain more than 2 oxygen atoms and more than 2 atoms of ur; and it is possible that the ring system of three to ten elements is mono-, di- or trisubstituted with halogen, cyano, nitro, hydroxy, C? -C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C3-Cg cycloalkyl , C5-C7 cycloalkenyl, C5-C8 cycloalkynyl, Ci-Ce haloalkyl, C2-Cg haloalkenyl, C2-C6 haloalkynyl, C3-C6 haloalkyloxy, C5-C7 halocycloalkenyl, C5-C8 haloalkyl cycloalkyl, C? -C4 alkoxy, haloalkoxy C? -C 4, C 1 -C 4 alkylthio, C 1 -C 4 haloalkylthio, C 1 -C 4 alkylinyl, C 1 -C 4 alkylonyl, C 1 -C 4 alkylamino, C 2 -C 4 dialkylamino, C 3 -C 6 cycloalkylamino, C 1 -C 6 -cycloalkylamino C 3 alkyl C6, C2-C4 alkylcarbonyl, C2-C6 alkoxycarbonyl, C2-C6 alkylaminocarbonyl, C3-C6 dialkylaminocarbonyl ?, C2-C6 alkoxycarbonyloxy, C2-C6 alkylaminocarbonyloxy f C3-C6 dialkylaminocarbonyloxy, C3-C6 trialkylsilyl or phenyl, where it is possible that the Phenyl group is in turn substituted with hydroxy, Ci-Cß alkyl, C?-C6 haloalkyl, C?-C6 alkylthio, C?-C6 haloalkylthio, C3-C6 alkenylthio, C3-C6 haloalkenylthio, C3-C6alkynylthio, C?-C3alkyl-C?-C3alkylthio, C2-C4alkylcarbonylC?-C3alkylthio, C2-C4alkoxycarbonyl-C1-C3alkylthio, C1-C3 cyano-alkylthio, alkylinyl Ci-Ce, haloalkylinyl Ci-Cd, alkylonyl C? -C6, haloalkylonyl C? -C6, aminoonyl, alkylaminoonyl C? -C2, N, N-di (C? -C2 alkyl) aminoonyl, di (C1-C4 alkyl) amino, halogen, cyano or nitro; and where the substituents on the nitrogen atoms in the ring systems are other than halogen; X is oxygen, NH or C 1 -C 4 alkyl; And it is a monocyclic or bicyclic ring system fused of three to ten elements that can be partially saturated or totally saturated and that can contain 1 to 4 heteroatoms selected from the group formed by nitrogen, oxygen and sulfur, where it is not possible for each system of rings contains more than 2 oxygen atoms and more than 2 sulfur atoms; and it is possible that the ring system of three to ten elements is mono-, di- or trisubstituted with halogen, cyano, nitro, hydroxy, Ci-Cß alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C3-C6 cycloalkyl, C5-C7 cycloalkenyl, C5-C8 cycloalkynyl, C6-C6 haloalkyl, C2-C6 haloalkenyl, C2-C6 haloalkynyl, C3-C6 haloalkyl, C5-C7 halocycloalkenyl, C5-C8 halocycloalkynyl, C? -C4 alkoxy, haloalkoxy C? -C 4, C 1 -C 4 alkylthio, C 1 -C 4 haloalkylthio, C 1 -C 4 alkylsulfinyl, C 1 -C 4 alkylsulfonyl, C 1 -C 4 alkylamino, C 2 -C 4 dialkylamino, C 3 -C 4 cycloalkylamino, C 1 -C 6 cycloalkylamino C 3 -C 6 alkyl, C 2 alkylcarbonyl -C4, C2-C6 alkoxycarbonyl, C2-C6 alkylaminocarbonyl, C3-C6 dialkylaminocarbonyl, C2-C6 alkoxycarbonyloxy, 2-C6 alkylaminocarbonyloxy, C3-Cd dialkylaminocarbonyloxy or C3-C6 trialkylsilyl, or with a fused monocyclic or bicyclic ring system of three to ten elements that can be aromatic, be partially saturated or totally saturated and that can c have 1 to 4 heteroatoms selected from the group consisting of nitrogen, oxygen and sulfur, where it is not possible for each ring system to contain more than 2 oxygen atoms and more than 2 sulfur atoms; and it is possible that the ring system of three to ten elements is mono-, di- or trisubstituted with halogen, cyano, nitro, hydroxy, Ci-Ce alkyl, C2-Ce alkenyl, C2-Ce alkynyl, C3-C6 cycloalkyl, C5-C7 cycloalkenyl, C5-C8 cycloalkynyl, C? -Cg haloalkyl, C2-C haloalkenyl? , C2-C6haloalkynyl, C3-C6halocycloalkyl, C5-C7halocycloalkenyl, Cs-C8halocycloalkynyl, C?-C4 alkoxy, C 1 -C 4 haloalkoxy, C?-C 4 alkylthio, C halo-C4 haloalkylthio, C 1 -C 4 alkylsulfinyl, alkylsulfonyl C1-C4, C alqu-C4 alkylamino, C2-C4 dialkyl, C3-C6 cycloalkylamino, C?-C6-cycloalkylamino C3-C6 alkyl, C2-C4 alkylcarbonyl, C2-C6 alkoxycarbonyl, C2-C6 alkylaminocarbonyl, C3 dialkylaminocarbonyl -C6, C2-C6 alkoxycarbonyloxy, C2-C6 alkylaminocarbonyloxy, C3-C6 dialkylaminocarbonyloxy, C3-C6 trialkylsilyl or phenyl, where it is possible for the phenyl group to be in turn substituted with hydroxy, C? -C6 alkyl, Ci-C? Haloalkyl , C 1 -C 6 alkylthio, C 1 -C 6 haloalkylthio, C 3 -C 6 alkenylthio, C 3 -C 6 haloalkenylthio, C 3 -C 4 alkynylthio, C 1 -C 3 alkoxy C 1 -C 3 alkylthio, C 2 -C 4 alkylcarbonyl C 1 -C 3 alkylthio, C 2 alkoxycarbonyl -C4-C 1 -C 3 alkylthio, C 1 -C 3 cyano-alkylthio, C 1 -C 6 alkylsulfinyl, C 1 -C 6 haloalkylsulfinyl, C 1 -C 6 alkylsulfonyl, C 1 -C 6 haloalkylsulfonyl, aminosulfonyl, C 1 -C 2 alkylaminosulfonyl, N, N-di (Ci-C 2 alkyl) aminosulfonyl, di (C 1 -C 4 alkyl) amino, halogen, cyano or nitro; and wherein the substituents on the nitrogen atoms in the ring systems are other than halogen; p is 0 or 1; q is 0 or 1; B is a ring system of three to four elements that may be totally or partially saturated and may contain 1 to 4 heteroatoms selected from the group consisting of nitrogen, oxygen and sulfur, where it is possible for the ring system of 3 to 4 elements is mono-, di- or trisubstituted with halogen, cyano, nitro, hydroxy, C? -C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C3-C6 cycloalkyl, C5-C7 cycloalkenyl, C5-C8 cycloalkynyl, haloalkyl C -C6, C2-C6 haloalkenyl, C2-C6 haloalkynyl, C3-C6 haloalkyl, C5-C7 haloalkenyl, C5-C8 haloalkyloxy, C1-C4 alkoxy, C1-C4 haloalkoxy, C1-C4 alkylthio, C1-C4 haloalkyl, alkylsulfinyl C? -C, C3-C4 alkylsulfonyl, C? -C4 alkylamino, C2-C4 dialkylamino, C3-C6 cycloalkylamino, C? -C6 alkyl-C3-C6 cycloalkylamino, C2-C4 alkylcarbonyl, C2-C6 alkoxycarbonyl, C2 alkylaminocarbonyl -C6, C3-? dialkylaminocarbonyl, C2-C6 alkoxycarbonyloxy, C2-C6 alkylaminocarbonyloxy, C3-C6 dialkylaminocarbonyloxy or C3-C6 trialkylsilyl, or with a monocyclic or bicyclic ring system fused of three to ten elements that can be aromatic, partially saturated or totally saturated and may contain 1 to 4 heteroatoms selected from the group consisting of nitrogen, oxygen and sulfur, where it is not possible for each ring system to contain more than 2 oxygen atoms and more than 2 sulfur atoms; and it is possible that the ring system of three to ten elements is mono-, di- or trisubstituted with halogen, cyano, nitro, hydroxy, CX-C6 alkyl, C-C6 alkenyl, C2-C6 alkynyl, C3-C6 cycloalkyl, C5-C7 cycloalkenyl, C5-C8 cycloalkynyl, C6-C6 haloalkyl, C2-C6 haloalkenyl, C2-C6 haloalkynyl, C3-C6 halocycloalkyl, C5-C7 halocycloalkenyl, C5-C8 halocycloalkynyl, CX-C4 alkoxy, haloalkoxy C? C4, C 1 -C 4 alkylthio, C 1 -C 4 haloalkylthio, C 1 -C 4 alkylsulfinyl, C 1 -C 4 alkylsulfonyl, C 1 -C 4 alkylamino, C 2 -C 4 dialkylamino, C 3 -C 6 cycloalkylamino, C 1 -C 6 cycloalkylamino C 4 -C 6 alkyl, C 2 alkylcarbonyl -C4, C2-C6 alkoxycarbonyl, C2-C6 alkylaminocarbonyl, C3-C6 dialkylaminocarbonyl, C2-C6 alkoxycarbonyloxy, C2-C6 alkylaminocarbonyloxy, C3-C6 dialkylaminocarbonyloxy, C3-C6 trialkylsilyl or phenyl, where it is possible for the phenyl group to be at its once substituted with hydroxy, C? -C6 alkyl, C? -C6 haloalkyl, C-C6 alkylthio, C? -C6 haloalkylthio, C3-C6 alkenylthio, halo C3-C6 alkenylthio, C3-C6alkynylthio, C alco-C3alkoxy-C1-C3alkylthio, C2-C4alkylcarbonyl-Cilt-C3alkylthio, C2-C4alkoxycarbonyl-C1-C3alkylthio, cyano-Cilt-C3alkylamino, alkylsulfinyl Ci-Ce, haloalkylsulfinyl C? -C6, alkylsulfonyl C? ~ C6, haloalkylsulfonyl C? ~ C6, aminosulfonyl, alkylaminosulfonyl C? -C2, N, N-di (C? -C2 alkyl) aminosulfonyl, di (C? alkyl? -C4) amino, halogen, cyano or nitro; and wherein the substituents on the nitrogen atoms in the ring systems are other than halogen; wherein each Ri independently is halogen, nitro, cyano, hydroxy, C? -C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C3-C6 cycloalkyl, C? -C6 haloalkyl, C2-C6 haloalkenyl, C2-C6 haloalkynyl, C3-C6 haloalkyl, C 1 -C 4 alkoxy, C 1 -C 4 haloalkoxy, C 1 -C 4 alkylthio, C 1 -C 4 haloalkylthio, C 1 -C 4 haloalkylsulfinyl, C 1 -C 4 haloalkylsulfonyl, C 1 -C 4 alkylsulfinyl, C 1 -C 4 alkylsulfonyl, C 1 alkylamino; C4, C2-C4 dialkylamino, C3-C6 cycloalkylamino, C6-C6 alkyl, C3-C6 cycloalkylamino, C2-C4 alkylcarbonyl, C2-C6 alkoxycarbonyl, C2-C6 alkylaminocarbonyl, C3-C6 dialkylaminocarbonyl, C2-C6 alkoxycarbonyloxy, C2-C6 alkylaminocarbonyloxy, C3-C6 dialkylaminocarbonyloxy or C3-C6 trialkylsilyl, phenyl, benzyl, or phenoxy, or phenyl, benzyl or phenoxy mono-, di- or trisubstituted with halogen, cyano, nitro, halogen, Ci-Cß alkyl, alkenyl C2-C6, C2-C6 alkynyl, C3-C6 cycloalkyl, Ci-Cß haloalkyl, C2-C6 haloalkenyl, C-C6 haloalkynyl, C3-C6 halocycloalkyl, alco xi C1-C4, C1-C4 haloalkoxy, C1-C4 alkylthio, C1-C4 haloalkylthio, C1-C4 alkylsulfinyl, Ci-C4 alkylsulfonyl, C?-C4 alkylamino, C2-C4 dialkylamino, C3-C6 cycloalkylamino, C alquilo-alkyl C6-C3-C6 cycloalkylamino, C2-C4 alkylcarbonyl, C2-C6 alkoxycarbonyl, C2-C6 alkylaminocarbonyl, C3-C6 dialkylaminocarbonyl, C2-Cg alkoxycarbonyloxy, C2-C6 alkylaminocarbonyloxy, C3-C6 dialkylaminocarbonyloxy, C3-C6 trialkylsilyl; n is O, 1, 2 or 3; each of R and R 3, which may be the same or different, represent hydrogen, C 1 -C 6 alkyl, C 2 -C 6 alkenyl, C 6 alkynyl or C 3 -C 8 cycloalkyl; or C 1 -C 6 alkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl or C 3 -C 8 cycloalkyl substituted with one or more substituents selected from halogen, nitro, cyano, hydroxy, C 1 -C 4 alkoxy, C 1 -C 4 haloalkoxy, C 1 alkylthio -C 4, C 1 -C 4 haloalkylthio, C 1 -C 4 alkylsulfinyl, C 1 -C 4 alkylsulfonyl, C 1 -C 4 alkylamino, C 2 -C 4 dialkylamino, C 3 -C 6 cycloalkylamino and C 1 -C 6 alkylcycloalkylamino C 3 D is phenyl, 2-pyridyl , 3-pyridyl, or 4-pyridyl; or phenyl, 2-pyridyl, 3-pyridyl or 4-pyridyl mono-, di- or trisubstituted with C 1 -C 6 alkyl, C 3 -C 6 cycloalkyl C 1 -C 6 haloalkyl, halogen, cyano, C 1 -C 4 alkoxy, haloalkoxy C 1 - C4, C 1 -C 4 alkylthio, C 1 -C 4 haloalkylthio, C 1 -C 4 alkylsulfinyl, C 1 -C 4 alkylsulfonyl, C 1 -C 4 haloalkylsulfinyl, or C 1 -C 4 haloalkylsulfonyl, or D is a group R4, R4X Rio, R17, and R19 independently of each other, are hydrogen, C? -C6 alkyl, C3-C6 cycloalkyl, Ci-Cg haloalkyl, halogen, cyano, C1-C4 alkoxy, C1-C4 haloalkoxy, C2-C4 alkoxycarbonyl C 1 -C 4 alkylthio, C 1 -C 4 haloalkylthio, C 1 -C 4 alkylsulfinyl, C 1 -C 4 alkylsulfonyl, C 1 -C 4 haloalkylsulfinyl or C 1 -C 4 haloalkylsulfonyl; R5, Rg, R8, Rn, R12, R15, Riβ and Ri8 independently of each other, are C?-C6 alkyl, or C?-C6 alkyl mono-, di- or trisubstituted with halogen, cyano, nitro, hydroxy, alkoxy C ? -C4, C-C4 alkoxycarbonyl, C1-C4 alkylthio, C1-C4 alkylsulfinyl, C1-C4 alkylsulfonyl, C1-C4 alkylamino, C2-C4 dialkylamino or C3-C6 cycloalkylamino; or are phenyl, 2-pyridyl, 3-pyridyl, or 4-pyridyl; or are phenyl, 2-pyridyl, 3-pyridyl or 4-pyridyl mono-, di- or trisubstituted with C 1 -C 6 alkyl, C 3 -C 6 cycloalkyl C 1 -C 6 haloalkyl, halogen, cyano, C 1 -C 4 alkoxy, haloalkoxy C 1 -C 4, C 1 -C 4 alkylthio, C 1 -C 4 haloalkylthio, C 1 -C 4 alkylsulfinyl, C 1 -C 4 alkylsulfonyl, C 1 -C 4 haloalkylsulfinyl, or haloalkylsulfonyl C 1 -C, R 7, Rg, R 13 and R 14 independently of each other, are hydrogen, alkyl C? -C6, haloalkyl C? ~ Cg, C2-Cg alkenyl, C2-C6 haloalkenyl, C3-Cg alkenyl or C3-C haloalkenyl and agronomically acceptable salts / isomers / enantiomers / tautomers / N-oxides of said compounds. Compounds I having at least one basic center can form, for example, acid addition salts, for example, strong inorganic acids, such as mineral acids, for example, perchloric acid, sulfuric acid, nitric acid, nitrous acid, phosphorous acid or hydrohalic acid with strong inorganic carboxylic acids, such as C1-C alkancarboxylic acids which are unsubstituted or substituted, for example, with halogen, for example, acetic acid, such as saturated or unsaturated dicarboxylic acids, for example oxalic acid, malonic acid, succinic acid, maleic acid, fumaric acid, or phthalic acid, such as hydroxycarboxylic acids, for example, ascorbic acid, lactic acid, malic acid, tartaric acid, or citric acid, or such as benzoic acid or with organic sulfonic acids such as C 1 -C 4 alkane- or arylsulfonic acids, which are unsubstituted or substituted, for example, with halo for example, with methan- or p-toluene sulphonic acids. The compounds (I) having at least one acidic group can form, for example, salts with bases, for example, mineral salts, such as alkali metal or alkaline earth metal salts, for example, sodium, potassium or magnesium salts. , or salts with ammonia or an organic amine such as morpholine, piperidine, pyrrolidine, a mono-, di- or tri-alkylamine, for example, ethylene-, diethylene-, triethyl-, or dimethylpropylamine, or a mono-, di- - or trihydroxy-lower alkylamine, for example, mono-, di- or triethanolamine. When appropriate, the corresponding internal salts can be formed further. Agrochemically advantageous salts are preferred within the scope of the invention; however, the invention also encompasses salts which have a disadvantage for agrochemical use, for example salts which are toxic to bees or fish, and which are employed, for example, for the isolation or purification of free (I) compounds or agrochemically usable salts of these. Due to the close relationship between the compounds (I) in free form and in the form of their salts, for the purposes of the invention, the free compounds (I) or their salts mentioned above and below will be interpreted respectively, as including when appropriate the corresponding salts or the free compounds (I). Analogously, the same applies to the tautomers of the compounds (I) and their salts. In general, the free form is the preferred form in each case. The alkyl groups mentioned in the definitions of substituents can be straight or branched chain and are, for example, methyl, ethyl, n-propyl, isopropyl, n-butyl, sec-butyl, iso-butyl, ter- butyl, pentyl, hexyl, heptyl and octyl and their branched isomers. The alkoxy, alkenyl and alkynyl radicals are derivatives of the aforementioned alkyl radicals. The alkenyl and alkynyl groups may be mono- or polyunsaturated. Halogen is usually fluorine, chlorine, bromine or iodine. This also applies, corresponding to halogen in combination with other meanings, such as haloalkyl or halophenyl. The haloalkyl groups preferably have a chain length of from 1 to 6 carbon atoms. The haloalkyl is, for example, fluomethyl, difluoromethyl, trifluoromethyl, chloromethyl, dichloromethyl, trichloromethyl, 2,2,2-trifluoroethyl, 2-fluoroethyl, 2-chloroethyl, pentafluoroethyl, 1,1-difluoro-2,2,2-trichlorethyl. , 2,2,3,3-tetrafluoroethyl and 2, 2, 2-trichlorethyl; preferably trichloromethyl, difluoromoromethyl, difluoromethyl, trifluoromethyl and dichlorofluoromethyl. Suitable haloalkenyl groups and alkenyl groups which are mono- or polysubstituted with halogen, where the halogen is fluorine, chlorine, bromine and iodine, and in particular fluorine and chlorine, for example 2, 2-difluor-1-methylvinyl, 3- fluorpropenyl, 3-chloropropenyl, 3-bromopropenyl, 2,3,3-trifluorpropenyl, 2,3,3-trichloropropenyl and 4,4,4-trifluorbut-2-en-1-yl. Among the C3-C20 alkenyl groups which are mono-, di- or trisubstituted with halogen, preference is given to those having a chain length of from 3 to 5 carbon atoms. Suitable haloalkynyl groups are, for example, alkynyl groups which are mono- or polysubstituted with halogen, where the halogen is bromine, iodine and in particular fluorine and chlorine, for example 3-fluoropynyl, 3-chloropropinyl, 3-bromopropinyl, 3, 3, 3-trifluoropropynyl and 4, 4, 4-trifluorbut-2-yn-1-yl. Among the alkynyl groups that are mono- or polysubstituted with halogen, those having a chain length of from 3 to 5 carbon atoms are preferred. The alkoxy groups preferably have a preferred chain length of from 1 to 6 carbon atoms. Alkoxy is, for example, methoxy, ethoxy, propoxy, i-propoxy, n-butoxy, isobutoxy, sec-butoxy and tert-butoxy and also the pentyloxy and hexyloxy isomeric radicals; preferably methoxy and ethoxy. Alkoxycarbonyl is for example, methoxycarbonyl, ethoxycarbonyl, propoxycarbonyl, isopropoxycarbonyl, n-butoxycarbonyl, isobutoxycarbonyl, sec-butoxycarbonyl or tert-butoxycarbonyl; preferably methoxycarbonyl or ethoxycarbonyl. The haloalkoxy groups preferably have a chain length of from 1 to 6 carbon atoms. Haloalkoxy is, for example, fluormetoxy, difluoromethoxy, trifluoromethoxy, 2,2,2-trifluoroethoxy, 1,1,2,2-tetrafluoroethoxy, 2-fluoroethoxy, 2-chloroethoxy, 2,2-difluoroethoxy and 2,2,2- trichloroethoxy; preferably difluoromethoxy, 2-chloroethoxy and trifluoromethoxy. The alkylthio groups preferably have a chain length of from 1 to 6 carbon atoms. Alkylthio is, for example, methylthio, ethylthio, propylthio, isopropylthio, n-butylthio, isobutylthio, sec-butylthio or tert-butylthio, preferably methylthio and ethylthio. Alkylsulfinyl is, for example, methylsulfinyl, ethylsulfinyl, propylsulfinyl, isopropylsulfinyl, n-butylsulfinyl, isobutylsulfinyl, sec-butylsulfinyl, tert-butylsulfinyl; preferably methylsulfinyl and ethylsulfinyl. Alkylsulfonyl is, for example, methylsulfonyl, ethylsulfonyl, propylsulfonyl, isopropylsulfonyl, n-butylsulfonyl, isobutylsulfonyl, sec-butylsulfonyl or tert-butylsulfonyl; preferably methylsulfonyl or ethylsulfonyl. The alkoxyalkoxy groups preferably have a chain length of from 1 to 8 carbon atoms. Examples of alkoxyalkoxy groups are methoxymethoxy, methoxyethoxy, methoxypropoxy, ethoxymethoxy, ethoxyethoxy, propoxymethoxy or butoxybutoxy. Alkylamino is, for example, methylamino, ethylamino, n-propylamine, isopropylamino or isomeric isylamines. Dialkylamino is, for example, dimethylamino, methylethylamino, diethylamino, n-propylmethylamino, dibutylamino and diisopropylamino. Preference is given to methylamino groups having a chain length of from 1 to 4 carbon atoms. The alkoxyalkyl groups preferably have a chain length of 1 to 6 carbon atoms. Alkoxyalkyl is, for example, methoxymethyl, methoxyethyl, ethoxymethyl, ethoxyethyl, n-propoxymethyl, n-propoxyethyl, isopropoxymethyl or isopropoxyethyl. The alkylthioalkyl groups preferably have from 1 to 8 carbon atoms. Alkylthioalkyl is, for example, methylthiomethyl, methylthioethyl, ethylthiomethyl, ethylthioethyl, n-propylthiomethyl, n-propylthioethyl, isopropylthiomethyl, isopropylthioethyl, butylthiomethyl, butylthioethyl or butylthiobutyl. Cycloalkyl groups preferably have from 3 to 6 carbon atoms in the ring, for example, cyclopropyl, cyclobutyl, cyclopentyl and cyclohexyl. Phenyl also as part of a substituent such as phenoxy, benzyl, benzyloxy, benzoyl, phenylthio, phenylalkyl, phenoxyalkyl, may be substituted. In this case, the substituents can be in the ortho, meta or para position. Preferred substituent positions are the ortho and para positions at the point of attachment of the ring. Examples for B as an optionally substituted three to four element ring system, which is completely or partially saturated and can contain a heteroatom selected from the group consisting of nitrogen, oxygen and sulfur, are cyclopropyl, methyl-cyclopropyl, cyclopropenyl, cyclobutyl, cyclobutenyl , According to the present invention, a fused monocyclic or bicyclic ring system of three to ten elements which may be partially saturated, is, depending on the number of ring elements, for example, selected from the group consisting of cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, wherein said cycloalkyl groups on the other hand can preferably be unsubstituted or substituted with C? -C6 alkyl or halogen or is where each R2g is methyl, each R27 and each R28 are independently hydrogen, C1-C3 alkyl, C1-C3 alkoxy, C1-C3 alkylthio or trifluoromethyl, X4 is oxygen or sulfur and r = 1, 2, 3 or 4. When not indicates valence free in these definitions, for example, as in the linkage site is located at the carbon atom labeled "CH" or in a case such as, for example, at the binding site indicated at the far left end. The second valence for the divalent ring system of the A or Y substituent may be located at any appropriate ring position. According to the present invention, a fused monocyclic or bicyclic ring system of three to ten elements which may be aromatic, partially saturated or fully saturated, is, depending on the number of ring elements, for example, selected from the group consisting of cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, wherein said cycloalkyl groups on the other hand can preferably be unsubstituted or substituted with Ci-C alkyl or halogen, or is phenyl; benzyl; naphthyl or the following heterocyclic groups: pyrrolyl; pyridyl; pyrazolyl; pyrimidyl; pyrazinyl; imidazolyl; thiadiazolyl; quinazolinyl; Furyl Oxadiazolyl; indolizinyl; pyranyl; isobenzofuranyl; thienyl; naphthyridinyl; (L-methyl-lH-pyrazol-3-yl) -; (1-ethyl-lH-pyrazol-3-yl) -; (l-propyl-lH-pyrazol-3-yl) -; (1H-pyrazol-3-yl) -; (1, 5-dimethyl-lH-pyrazol-3-yl) -; (4-chloro-l-methyl-lH-pyrazol-3-yl) -; (1H-pyrazol-1-yl) -; (3-methyl-lH-pyrazol-1-yl) -; (3, 5-dimethyl-lH-pyrazol-1-yl) -; (3-isoxazolyl) -; (5-methyl-3-isoxazolyl) -; (3-methyl-5-isoxazolyl) -; (5-isoxazolyl) -; (lH-pyrrol-2-yl) -; (l-methyl-lH-pyrrol-2-yl) -; (lH-pyrrol-1-yl) -; (l-methyl-lH-pyrrol-3-y1) -; (2-furanyl) -; (5-methyl-2-furanyl) -; (3-furanyl) -; (5-methyl-2-thienyl) -; (2-thienyl) -; (3-thienyl) -; (l-methyl-lH-imidazol-2-yl) -; (ÍH-imidazol-2-yl) -; (1-methyl-lH-imidazol-4-yl) -; (1- methyl-lH-imidazol-5-yl) -; (4-methyl-2-oxazolyl) -; (5-methyl-2-oxazolyl) -; (2-oxazolyl) -; (2-methyl-5-oxazolyl) -; (2-methyl-4-oxazolyl) -; (4-methyl-2-thiazolyl) -; (5-methyl-2-thiazolyl) -; (2-thiazolyl) -; (2-methyl-5-thiazolyl) -; (2-methyl-4-thiazolyl) -; (3-methyl-4-isothiazolyl) -; (3-methyl-5-isothiazolyl) -; (5-methyl-3-isothiazolyl) -; (1-methyl-lH-l, 2, 3-triazol-4-yl) -; (2-methyl-2H-l, 2,3-triazol-4-yl) -; (4-methyl-2H-1, 2,3-triazol-2-yl) -; (1-methyl-lH-1, 2,4-triazol-3-yl) -; (1, 5-dimethyl-lH-l, 2,4-triazol-3-yl) -; (3-methyl-lH-1,2,4-triazol-1-yl) -; (5-methyl-lH-1,2,4-triazol-1-yl) -; (4,5-dimethyl-4H-l, 2,4-triazol-3-yl) -; (4-methyl-H-1, 2,4-triazol-3-yl) -; (4H-1,2, 4-triazol-4-yl) -; (5-methyl-1,2,8-oxadiazol-4-yl) -; (1, 2, 3-oxadiazol-4-yl) -; (3-methyl-1,2,4-oxadiazol-5-yl) -; (5-methyl-1,2,4-oxadiazol-3-yl); (4-methyl-3-furazanyl) -; (3-furazanil) -; (5-methyl-l, 2, -oxadiazol-2-yl) -; (5-methyl-1,2,3-thiadiazol-4-yl) -; (1, 2, 3-thiadiazol-4-yl) -; (3-methyl-1,2,4-thiadiazol-5-yl) -; (5-methyl-1,2,4-thiadiazol-3-yl) -; (4-methyl-1, 2, 5-thiadiazol-3-yl) -; (5-methyl-1,3,4-thiadiazol-2-yl) -; (l-methyl-lH-tetrazol-5-yl) -; (lH-tetrazol-5-yl) -; (5-methyl-lH-tetrazol-1-yl) -; (2-methyl-2H-tetrazol-5-yl) -; (2-ethyl-2H-tetrazol-5-yl) -; (5-methyl-2H-tetrazol-2-yl) -; (2H-tetrazol-2-yl) -; (2-pyridyl) -; (6-methyl-2-pyridyl) -; (4-pyridyl) -; (3-pyridyl) -; (6-methyl-3-pyridazinyl) -; (5-methyl-3-pyridazinyl) -; (3-pyridazinyl) -; (4,6-dimethyl-2-pyrimidinyl) -; (4-methyl-2-pyrimidinyl) -; (2-pyrimidinyl) -; (2-methyl-4-pyrimidinyl) -; (2-chloro-4-pyrimidinyl) -; (2,6-dimethyl-4-pyrimidinyl) -; (4-pyrimidinyl) - (2-methyl-5-pyrimidinyl) -; (6-methyl-2-pyr-azinyl) -; (2-pyrazinyl) -; (4,6-dimethyl-1,3,5-triazin-2-yl) -; (4,6-dichloro-1,3,5-triazin-2-yl) -; (1, 3, 5-triazin-2-yl) -; (4-methyl-l, 3,5-triazin-2-yl) -; (3-methyl-1,2-triazin-5-yl) -; (3-methyl-1,2,4-triazin-6-yl) -; -? ~~~ C ° - < ! where each R 2g is methyl, each R 27 and each R 28 are independently hydrogen, C 1 -C 3 alkyl, C 1 -C 3 alkoxy, C 1 -C 3 alkylthio or trifluoromethyl, X 4 is oxygen or sulfur and r = 1, 2, 3 or 4. When no free valence is indicated in these definitions, for example, as in ° the linkage site is located at the carbon atom labeled "CH" or in a case such as, for example, at the binding site indicated at the far left end. Preference is given to sub-groups of compounds of formula I wherein a) p and / or q is 0; b) E and / or Z is oxygen; and / or c) R2 and / or R3 is hydrogen and / or d) A is a saturated monocyclic divalent ring system of three to six elements. X is preferably oxygen, NH; N-Methyl or N-Ethyl. And it is preferably C3-C6 cycloalkyl, especially cyclopropyl.

R4 'is preferably hydrogen. Special mention must be made of the compounds of formula I in which Ri is selected from C 1 -C 4 alkyl, halogen, C 1 -C 5 haloalkyl, nitro, C 1 -C 4 alkoxy, C 1 -C 4 haloalkoxy, C 1 -C 4 alkylthio, C 1 -C 4 alkylsulfinyl. , C 1 -C 4 alkylsulfonyl, C 1 -C 4 haloalkylthio, C 1 -C 4 haloalkylsulfinyl and C 1 -C 4 haloalkylsulfonyl, in particular between halogen and C x Cg alkyl, preferably selected from methyl and halogen, more preferably selected from methyl and chlorine, and n is 1 or 2, preferably 1. The preferred position of Ri is meta for the group -C (Z) -N (R3) -AXYB. An outstanding group of compounds of formula I comprises those compounds wherein A is Ci-C alkylene which may be substituted by C3-C6 cycloalkyl, C2-C6 alkenyl, cyano, C1-C4 alkylthio, C1-C4 alkylsulfonyl, C1-C4 alkoxy , halogen or C? -C6 haloalkyl; or A is C3-C6 cycloalkylene. Preferably A is C3-C6 cycloalkylene, more preferably cyclopropylene. In preferred compounds of formula I, B is cyclopropyl, oxetanyl or cyclobutyl, preferably cyclopropyl. Special emphasis must also be given to the compounds of formula I wherein D is a group Di, where R5 is 2-pyridyl which can be substituted by halogen, preferably is mono-substituted with chloro at the 3-position of the pyridine ring and R1 is halogen, preferably chlorine or bromine, haloC6-C6alkyl, haloalkoxy C_-C more preferably 2,2,2-tr if luoretoxy, preferably haloalkyl Ci-Cg, more preferably trifluoromethyl. Preference is also given to compounds of formula I wherein in particular B is cyclopropyl or cyclobutyl which may be mono-di-, or trisubstituted with halogen, C 1 -C 4 alkyl, hydroxy, cyano, C 4 -C 4 alkoxy or alkylthio C ? -C4; or B is CH (CH2?), CH (CHMeO), CH- (CMe2?), CH (CH2S), CH (CH2OCH2), CH (CHMeOCH2), CH (CMe2? CH2), CH (CH2S- (0) 2CH2), CH (CHMeS (0) 2CH2), CH (CMe2S (0) 2CH2), C (Me) - (CH20), C (Me) (CHMeO), C (Me) - (CMe20), C (Me) - (CH2S), C (Me) - (CH2OCH2), C (Me) (CHMeOCH2), C (Me) - (CMe2 CH2), C (Me) - (CH2S (0) 2CH2), C (Me) - (CHMe-S (0) 2CH2) or C (Me) - (CMe2-S (0) 2CH2). In particular, the preferred compounds of formula B are cyclopropyl or cyclobutyl which may be substituted by halogen or methyl, in particular by chlorine, bromine or methyl; more preferably B is cyclopropyl.

DETAILED DESCRIPTION OF THE INVENTION The method according to the invention for preparing compounds of formula I is carried out analogously to known processes, for example, those described in WO 01/70671, WO 03/016284, WO 03/015518 WO 04/033468 and WO 04/067528. The process for the preparation of a compound of formula I, or when appropriate, a tautomer thereof, in each case in free form or in salt form, comprises, for example, a) to prepare a compound of formula I in the which R2 is hydrogen and E and Z are oxygen, or, where appropriate, a tautomer and / or a salt thereof, by reaction of a compound of the formula wherein Ri, n, and D have the meanings indicated for formula I, or when appropriate, a tautomer and / or a salt thereof with a compound of the formula HN (R3) - (A) q- (X) p AND B (III), wherein R3, p, q, A, X, Y and B have the meanings indicated for formula I, or when appropriate, with a tautomer and / or a salt thereof or, b) to prepare a compound of formula I or, when appropriate, a tautomer and / or a salt thereof, reacting a compound of the formula wherein R 1 R2, n, Z and D have the meanings indicated for the formula I, and Xi is a leaving group or when appropriate, a tautomer and / or a salt thereof with a compound of the formula HN (RX- (A) s- (XX-Y-B III wherein R3, p, q, A, X, Y and B have the meanings indicated for formula I, or when appropriate, with a tautomer and / or a salt thereof or, c) to prepare a compound of the formula I or when a tautomer and / or a salt thereof is appropriate by reaction of a compound of the formula wherein R.sup.lf, R.sup.3, n, p, q, A, X, Y, Z and B have the meanings indicated for formula I, or when appropriate, a tautomer and / or a salt thereof with a compound of the formula X2C (= 0) D (VI), where Ri has the meaning indicated for formula I; and X2 is a leaving group, or when appropriate, with a tautomer and / or a salt thereof and / or converting a compound of the formula I or when a tautomer thereof is appropriate in each case in free form or in the form of salt to another compound of the formula I or, where appropriate, a tautomer thereof, separating an isomer mixture, which can be obtained according to the process, and isolating the desired isomer and / or converting a free compound of the formula I, or when a tautomer thereof is appropriate to a salt, or a salt of a compound of the formula I or, where appropriate, a tautomer thereof in the free compound of the formula I or when appropriate, a tautomer thereof in another salt The compounds of formula II are new and have been specially developed for the preparation of the compounds of formula I according to the present invention. The compounds of formula II therefore constitute another object of the present invention. The compounds of formula II can be prepared analogously to the methods described in WO 04/111030. The compounds of formula V are also novel and are especially developed for the preparation of the compounds of formula I according to the present invention. The compounds of formula V are therefore another object of the present invention. Preferred are compounds of formula V, wherein Ri is C 1 -C 4 alkyl, halogen, C 1 -C 5 haloalkyl, nitro, C 1 -C 4 alkoxy, C 1 -C 4 haloalkoxy, C 1 -C 4 alkylthio, C 1 -C 4 alkylsulfinyl, C 1 -C 4 alkylsulfonyl C4, haloalkylthio Ci-C4, haloalkylsulfinyl C? -C or haloalkylsulfonyl C? ~ C4; R2 and R3 are hydrogen; A is Ci-Cβ alkylene which may be substituted by C3-Cg cycloalkyl, C2-C6 alkenyl, cyano, C1-C4 alkylthio, C1-C4 alkylsulfonyl, C1-C4 alkoxy, halogen or C? -β haloalkyl; or A is C3-C6 cycloalkylene; p and q are, independently of each other, 0 or 1; X is oxygen, NH; NCH3 or NC2H5; Y is C? -C4 alkylene, C2-C5 alkenylene or C3-C6 alkynylene or, C1-C4 alkylene, C2-C6 alkenylene or C3-C6 alkynylene substituted with halogen, C3-C cycloalkyl, C1-C4 alkylsulfonyl or C1-C4 alkoxy? -C4; and B is cyclopropyl or cyclobutyl which may be mono-di-, or trisubstituted with halogen, C 1 -C 4 alkyl, hydroxy, cyano, C 1 -C alkoxy or C 1 -C 4 alkylthio; or B is CH (CH20), CH (CHMeO), CH- (CMe20), CH (CH2S), CH (CH20CH2), CH (CHMeOCH2), CH (CMe2OCH2), CH (CH2S- (0) 2CH2), CH (CHMeS (0) 2CH2), CH (CMe2S (O) 2CH2), C (Me) - (CH20), C (Me) (CHMeO), C (Me) - (CMe20), C (Me) - (CH2S ), C (Me) - (CH2OCH2), C (Me) (CHMeOCH2), C (Me) - (CMe2OCH2), C (Me) - (CH2S (O) 2CH2), C (Me) - (CHMe-S (0) 2CH2) or C (Me) - (CMe2-S (0) 2CH2), preferably B is cyclopropyl or cyclobutyl which may be mono-di-, or trisubstituted with halogen, C? -C4 alkyl, hydroxy, cyano, C 4 -C 4 alkoxy or C 1 -C 4 alkylthio. The process for the preparation of a compound of formula V or when a tautomer thereof is appropriate, in each case in free form or in salt form, comprises, for example, to prepare a compound of formula V or when a tautomer and / or a salt of the same, reacting a compound of the formula Where R_, R2, n have the meanings indicated in formula I, with a compound of formula HN (R3) - (A) q- (X) p-Y-B (III), wherein R3 / p, q, A, X, Y and B have the meanings for the formula I or when appropriate with a tautomer and / or a salt thereof. What has been mentioned above for the tautomers and / or salts of the compounds I, is applied analogously to the starting materials mentioned above and below, with respect to the tautomers and / or salts thereof. The reactions described above and below are carried out in a manner known per se, for example, in the absence, or normally in the presence of an appropriate solvent or diluent or a mixture thereof, where the process is carried out, according to as required with cooling to room temperature or with heating, for example, in a temperature range from about -80 ° C to the boiling point of the reaction mixture, preferably from about -20 ° C to about plus + 150 ° C, and, if required, in a sealed container, under reduced, normal or elevated pressure, in an atmosphere of inert gas and / or under anhydrous conditions. Particularly advantageous reaction conditions can be observed in the examples. Unless otherwise specified, the starting materials mentioned above and below, which are used for the preparation of the compounds I or, where appropriate, the tautomers thereof, in each case in free form or in salt form , are known or can be prepared by methods known per se, for example, in accordance with the information provided below.

Variant a) The reactants can react with each other as such, that is, without the addition of a solvent or diluent, for example, in the melt. In most cases, however, it is advantageous to add an inert solvent or diluent or a mixture thereof. Examples of such solvents or diluents that may be mentioned are: aromatic, aliphatic and alicyclic hydrocarbons and haiohydrocarbons such as benzene, toluene, xylene, mesitylene, tetralin, chlorobenzene, dichlorobenzene, bromobenzene, petroleum ether, hexane, cyclohexane, dichloromethane, trichloromethane, tetrachloromethane , dichloroethane, trichloroethene or tetrachloroethene. Esters such as ethyl acetate; ethers such as diethyl ether, dipropyl ether, diisopropyl ether, dibutyl ether, tert-butyl methyl ether, ethylene glycol monomethyl ether, ethylene glycol monomethyl ether, ethylene glycol dimethyl ether, dimethoxydiethyl ether, tetrahydrofuran or dioxane; ketones, such as acetone, methyl ethyl ketone or methyl isobutyl ketone; alcohols such as methanol, ethanol, propanol, isopropanol, butanol, ethylene glycol or glycerol; amides such as N, N-di-methylformamide, N, N-diethylformamide, N, N-dimethylacetamide, N-methylpyrrolidone or hexamethylphosphoric triamide; nitriles, such as acetonitrile or propionitrile; and sulfoxides such as dimethyl sulfoxide. The reaction was advantageously carried out in a temperature range from about -80 ° C to about + 140 ° C, preferably from about -30 ° C to about + 100 ° C, in many cases in the ambient temperature range of approximately + 80 ° C.

Variant b) Examples of suitable leaving groups Xi, in compounds IV are hydroxy, C?-C8 alkoxy, haloC C-C8 alkoxy, CX-C8 alkanoyloxy, mercapto, C?-C8-alkylthio, halo-Cilt-alkylthio?? C8, C 1 -C 8 alkylsulfonyloxy, C 1 -C 8 haloalkylsulfonyloxy, benzenesulfonyloxy, toluenesulfonyloxy and halogen, such as chlorine. Hydroxy, C?-C8 alkoxy and chloro are preferred. The reactants can react with each other as such, that is, without the addition of solvent or diluent. In most cases, however, it is advantageous to add an inert solvent or diluent or a mixture thereof. Examples of suitable solvents or diluents are those of the type described under variant a). The reaction was advantageously carried out in a temperature range of from about -80 ° C to about + 140 ° C, preferably from about -20 ° C to about + 100 ° C, in many cases in the range of between room temperature and the reflux temperature of the reaction mixture.

Variant c) Examples of appropriate leaving groups X2, in compounds VI are hydroxy, C?-C8 alkoxy, C?-C8 haloalkoxy, C?-C8 alkanoyloxy, mercapto, C?-C8-alkylthio, halo-Cilt-alkylthio; -C8, C 1 -C 8 alkylsulfonyloxy, C 1 -C 8 haloalkylsulfonyloxy, benzenesulfonyloxy, toluenesulfonyloxy and halogen, such as chlorine. Hydroxy, and chlorine are preferred. The reagents can react in the presence of a base. Examples of suitable bases for facilitating the separation of HX2 are alkali metal or alkaline earth metal hydroxides, alkali metal or alkaline earth metal hydrides, alkali metal or alkaline earth metal amides, alkali metal alkaline earth metal alkoxides, acetates of alkali metals or alkaline earth metals, alkali metal or alkaline earth metal carbonates, dialkylamides of alkali metals or alkaline earth metals or alkyl silyl amides of alkali metals or alkaline earth metals, alkylamines, alkylenediamines, free or N-alkylated cycloalkylamines saturated or unsaturated, basic heterocycles, ammonium hydroxides and carbocyclic amines. Examples which may be mentioned are sodium hydroxide, sodium hydride, sodium amide, sodium methoxide, sodium acetate, sodium carbonate, potassium tert-butoxide, potassium hydroxide, potassium carbonate, potassium hydride, lithium diisopropylamide. potassium bis (trimethylsilyl) amide, calcium hydride, triethylamine, diisopropylethylamine, triethylenediamine, cyclohexylamine, N-cyclohexyl-N, N-dimethylamine, N, N-diethylaniline, pyridine, 4- (N, N-dimethylamino) pyridine, quinuclidine, N-methylmorpholine, benzyltrimethylammonium hydroxide and 1,8-diaza-bicyclo [5.4.0] undec-7-ene (DBU). The reactants can react with each other as such, that is, without adding solvent or diluent. In most cases, however, it is advantageous to add an inert solvent or diluent or a mixture thereof. Examples of suitable solvents or diluents are of the type described under variant a). If the reaction is carried out in the presence of a base, the bases that are used in excess, such as triethylamine, pyridine, N-methylmorpholine, or N, N-diethylaniline, can also act as solvents or diluents. The reaction is advantageously carried out in a temperature range from about -80 ° C to about + 140 ° C, preferably from about -30 ° C to about + 100 ° C, in many cases in the range of temperature environment and approximately + 80 ° C. A compound I can be converted in a manner known per se into another compound I by replacement of one or more substituents of the starting compound I in the usual manner by another substituent (s) according to the invention. For example, in compounds I, where R2 is hydrogen, this hydrogen R2 can be replaced by a substituent R2, which is different from hydrogen; or - in compounds I, wherein R3 is hydrogen, this hydrogen R3 can be replaced with a substituent R3, which is different from hydrogen. Depending on the choice of the reaction conditions and the starting materials that are appropriate in each case, it is possible, for example, in a reaction stage only to replace one substituent with another substituent according to the invention, or a plurality of substituents it can be replaced by other substituents according to the invention in the same reaction step. The salts of the compounds I can be prepared in a manner known per se. Therefore, for example, the acid addition salts of the compounds I are obtained by treatment with an appropriate acid or with an appropriate ion exchange reagent and the salts with bases are obtained by treatment with an appropriate base or with a reagent of appropriate ion exchange. The salts of the compounds I can be converted in the usual manner to the free compounds I, the acid addition salts, for example, by treatment with an appropriate basic treatment or with an appropriate ion exchange reagent and salts with bases, for example, by treatment with an appropriate acid or with an appropriate ion exchange reagent. The salts of compounds I can be converted in a manner known per se to other salts of compounds I, acid addition salts, for example, in other acid addition salts, for example, by treatment of an inorganic acid salt, such as hydrochloride with an appropriate metal salt, such as a sodium, barium or silver salt, or an acid, for example with silver acetate, in an appropriate solvent in which an inorganic salt forming, for example, silver chloride, is insoluble and therefore precipitates from the reaction mixture. Depending on the process or the reaction conditions, the compounds I, which have salt-forming properties, can be obtained in free form or in the form of salts. The compounds I and, where appropriate, the tautomers thereof, in each case in free form or in salt form, may be present in the form of one of the possible isomers or in the form of a mixture of these, example, in the form of pure isomers, such as antipodes and / or diastereomers, or as isomeric mixtures, such as enantiomeric mixtures, for example, racemates, diastereomeric mixtures or mixtures of racemates, depending on the amount, absolute and relative configuration of the atoms Asymmetric carbon atoms that occur in the molecule and / or depending on the configuration of the non-aromatic double bonds that occur in the molecule; the invention relates to the pure isomers and also to all isomeric mixtures which are possible and should be understood in each case in this sense cited above, and then, even when they are not specifically mentioned in each case, the stereochemical details. The diastereomeric mixtures or racemate mixtures of the compounds of formula I in free form or in salt form, which can be obtained depending on which starting materials and processes have been chosen, can be separated in known manner into pure diastereomers or racemates based on the physicochemical differences of the components, for example, by fractional crystallization, distillation and / or chromatography. Enantiomeric mixtures, such as racemates, which can be obtained in a similar manner, can be resolved in the optical antipodes by known methods, for example, by recrystallization from an optically active solvent, by chromatography on chiral adsorbents, for example, liquid chromatography of high performance (HPLC) on acetyl cellulose, with the help of appropriate microorganisms, by dissociation with specific immobilized enzymes, through the formation of inclusion compounds, for example, using chiral crown ethers, when only one enantiomer is complexed, or by conversion to diastereomeric salts, for example, by reaction of a basic racemate as the final product with an optically active acid such as carboxylic acid, for example, camphor, tartaric or malic acid or sulphonic acid, for example camphor sulfonic acid, and separating the mixture diastereomeric that can be obtained in this way, by example, by fractional crystallization based on their different solubilities, to provide the diastereomers, from which the desired enantiomer can be released by the action of appropriate agents such as, for example, basic agents. The pure diastereomers or enantiomers can be obtained according to the invention not only by separating the appropriate isomeric mixtures, but also in general, by known methods of selective diastereo synthesis or selective enantio, for example, by carrying out the process according to the invention, with starting materials of an appropriate stereochemistry. It is advantageous to isolate or synthesize in each case the biologically more effective isomer, for example, the enantiomer or diastereomer, or the mixture of isomers, for example, an enantiomeric mixture or a diastereomeric mixture, if the individual components have a different biological activity. The compounds according to the invention and when appropriate the tautomers thereof, in each case in free form or in salt form, can also be obtained if appropriate in the form of hydrates and / or can include other solvents, such as example, those that may have been used for the crystallization of compounds that are present in solid form. The compounds according to the invention are preventively and / or curatively valuable active ingredients in the field of pest control, even under application regimes that have a very favorable biocidal spectrum and are well tolerated by warm blood species, fish and plants. . The active ingredients according to the invention act against all stages of development or against individual stages of development, of pests of animals that are normally sensitive, but also resistant, such as insects or representatives of the Acariña order. The insecticidal or acaricidal activity of the combinations according to the invention can manifest itself directly, that is, in the destruction of the pests, which occurs immediately or after a short lapse of time, for example, during the ecdysis , or indirectly, for example in a reduced oviposition and / or incubation regime, a good activity corresponding to a destruction (mortality) regime of at least 50 to 60%). Examples of the aforementioned animal pests are: of the order of Acariña, for example, Acarus served, Sheldoni mill, Aculus schlechtendali, Amblyomma spp., Argas spp., Boophilus spp., Brevipalpus spp., Bryobia praetiosa, Calipitrimerus spp., Chorioptes spp., Dermanyssus gallinae, Eotetranychus carpini, Eriophyes spp. , Hyalomma spp. , Ixodes spp. , Olygonychus pratensis, Ornithodoros spp., Panonychus spp., Phyllocoptruta oleivora, Polyphagotarsonemus latus, Psoroptes spp., Rhipicephalus spp. , Rhizoglyphus spp. , Sarcoptes spp. , Tarsonemus spp. and Tetranychus spp. of the order of Anoplura, for example, Haematopinus spp., Lmognathus spp., Pediculus spp. , Pemphigus spp. and Phylloxera spp.; of the order of the Coleoptera, for example, Agriotes spp. , Anthonomus spp. , Atomaria lmearis, Chaetocnema tibialis, Cos opolites spp., Curculio spp., Dermestes spp. , Diabrotica spp. , Epilachna spp. , Eremnus spp., Leptmotarsa decemlmeata, Lissorhoptrus spp., Melolontha spp. , Orycaephilus spp. , Otiorhynchus spp. , Phlyctmus spp., Popillia spp., Psylliodes spp., Rhizopertha spp., Scarabeidae, Sitophilus spp., Sitotroga spp., Tenebrio spp., Tpbolium spp. and Trogoderma spp .; of the order of the Diptera, for example, Aedes spp., Anthepgona soccata, Bibio hortulanus, Calliphora erythrocephala, Ceratitis spp., Chrysornyia spp., Culex spp. , Cuterebra spp. , Dacus spp. , Drosophila melanogaster, Fannia spp. , Gastrophilus spp. , Glossina spp. , Hypoderma spp. , Hyppobosca spp. , Lipomyza spp. , Lucilia spp. , Melanagromyza spp. , Musca spp. , Oestrus spp. , Orseolia spp., Oscmella fpt, Pegornyia hyoscyami, Phorbia spp., Rhagoletis pomonella, Sciara spp., Stomoxys spp., Tabanus spp. , Tannia spp. and Typula spp.; of the order of the Heteropteros, for example, Cimex spp., Distantiella theobroma, Dysdercus spp., Euchistus spp. , Eurygaster spp. , Leptocorisa spp. , Nezara spp. , Piesma spp. , Rhodmus spp. , Sahlbergella smgulaps, Scotmophara spp. and Triatoma spp .; of the order of the Homopteros, for example, Aleurothpxus loccosus, Aleyrodes brassicae, Aonidiella spp., Aphididae, Aphis spp., Aspidiotus spp., Bemisia tabaci, Ceroplaster spp. , Chrysomphalus aonidium, Chrysomphalus dictyospermí, Coccus hesperidum, Empoasca spp., Eriosoma lapgerum, Erythroneura spp. , Gascardia spp. , Laodelphax spp., Lecamum ate, Lepidosaphes spp., Macrosiphus spp., Myzus spp., Nephotettix spp., Nilaparvata spp., Parlatopa spp. , Pemphigus spp. , Planococcus spp. , Pseudaulacaspis spp. , Pseudococcus spp., Psylla spp., Pulvmaria aethiopica, Quadraspidiotus spp. , Rhopalosiphum spp. , Saissetia spp. , Scaphoideus spp., Schizaphis spp., Sitobion spp., Tpaleurodes vaporar íorum, Tpoza erytreae and Unaspis citri; of the order of Hymenoptera, for example, Acromyrmex, Atta spp. , Cephus spp. , Dippon spp. , Diprionidae, Gilpima polytoma, Hoplocampa spp., Lasius spp., Monomopum pharaonis, Neodiprion spp. , Solenopsis spp. and Vespa spp.; of the order of Isopteros, for example, Reticulitermes spp .; of the order of the Lepidoptera, for example, Acleris spp. , Adoxophyes spp. , Aegeria spp. , Agrotis spp. , Alabama argillaceae, Amylois spp. , Anticarsia gemmatalis, Archips spp., Argyrotaenia spp., Autographa spp., Busseola fusca, Cadra cautella, Carposma mpponensis, Chilo spp., Chopstoneura spp., Clysia ambiguella, Cnaphalocrocis spp. , Cnephasia spp. , Cochylis spp. , Coleophora spp. , Crocidolomia bmotalis, Cryptophlebia leucotreta, Cydia spp. , Diatraea spp., Diparopsis castanea, Eapas spp., Ephestia spp., Eucosma spp., Eupoecilia ambiguella, Euproctis spp., Euxoa spp., Grapholita spp., Hedya nubiferana, Heliothis spp., Hellula undalis, Hyphantpa cunea, Keifepa lycopersicella , Leucoptera scitella, Lithocollethis spp., Lobesia botrana, Lymantpa spp., Lyonetia spp., Malacosoma spp., Mamestra brassicae, Manduca sexta, Operophtera spp., Ostpma nubilalis, Pammene spp., Pandemis spp., Panolis flammea, Pectinophora gossypiela, Phthorimaea operculella, Pieris rapae, Pieps spp., Plutella xylostella, Prays spp., Scirpophaga spp. , Sesamia spp. , Sparganothis spp. , Spodoptera spp. , Synanthedon spp. , Thaumetopoea spp. , Tortpx spp. , Trichoplusia ni e Ypono euta spp.; of the order of the Malófagos, for example, Dama linea spp. and Trichodectes spp.; of the order of the Orthopterans, for example, Blatta spp., Blattella spp., Gryllotalpa spp., Leucophaea maderae, Locusta spp. , Pepplaneta spp. and Schistocerca spp.; of the order of the Psocópteros, for example, Liposcelis spp.; of the order of the Siphonaptera, for example, Cera tophyl l us spp. , Ctenocephal ides spp. Y Xenopsyl the cheopi s; of the order of the Thysanoptera, for example, Frankl iniella spp. , Hercinothrips spp. , Scirtothrips a uran ti i, Ta eniothrips spp. , Thrips palmi and Thrips taba ci; and of the order of the Thysanura, for example, Lepi sma sa ccha rina; The active ingredients according to the invention can be used to control, that is to say contain or destroy, pests of the aforementioned type, which occur in particular in plants, especially in useful and ornamental plants, in agriculture, in horticulture and in forests, or in organs such as fruits, flowers, foliage, stems, tubers or roots of such plants, and in some cases, even organs of plants that form at a point late in time, remain protected against these pests. Appropriate crops to which it is targeted are wheat, barley, rye, oats, rice, corn or sorghum; beet such as sugar beet or beet for fodder, fruits such as pome fruits, pip fruits or soft fruits, such as apples, pears, plums, peaches, almonds, cherries or berries, for example strawberries, raspberries or blackberries; legume crops such as beans, lentils, peas or soybeans; oleaginous plants, such as oilseed rape, mustard, poppy, olives, sunflowers, coconut, castor oil plants, cocoa beans or peanuts; cucurbits such as pumpkins, cucumbers or melons; fibrous plants such as cotton, flax, hemp or jute, citrus fruits such as oranges, lemons, grapefruits or tangerines; vegetables, such as spinach, lettuce, asparagus, cabbage, carrots, onions, tomatoes, potatoes or sweet pepper; lauraceae, such as avocados, cinnamon or camphor, and also tobacco, nuts, coffee, aubergines, sugar cane; tea, peppers, grapes; hop; family of bananas, latex and ornamental plants. The active ingredients according to the invention are especially suitable for controlling Aphis cra ccivora, Diabroti ca bla tea ta, Hel iothis virescens, Myzus persi cae, Pl u tella xylostella and Spodoptera li t toralis on cotton, vegetable, corn and rice crops. and soy. The active ingredients according to the invention are also especially useful for controlling Mamestra (preferably in vegetables), Cydia pomonella (preferably in apples), Empoasca (preferably in vegetables, vineyards), Leptinotarsa (preferably in potatoes) and Chilo supressalis (preferably in rice). The term "crops" should be construed also including crop plants that have been made tolerant to herbicides, such as bromoxynil or classes of herbicides (such as, for example, HPPD inhibitors, ALS inhibitors, e.g., primisulfuron, prosulfuron and trifloxysulfuron, inhibitors of EPSPS (5-enol-pirovil-shikimate-3-phosphate synthase), GS (glutamine synthetase) inhibitors) as a result of conventional culture methods or genetic engineering. Clearfield® summer rape (Cañóla) is an example of a culture that has been made tolerant to imidazolinones, for example, imazamox, by conventional breeding methods (mutagenesis). Examples of crops that have been converted to tolerant herbicides or herbicide classes by genetic engineering methods include glyphosate- and glufosinate-resistant maize varieties commercially available under the names Roundup Ready®, Herculex I® and LibertyLink®. The term "crops" should be interpreted, including also crop plants that have been transformed by the use of recombinant DNA techniques that are capable of synthesizing one or more toxins that act selectively, as is known, for example, the bacteria producing toxins, especially those of the genus Bacillus. Toxins that can be expressed by said transgenic plants, include, for example, insecticidal proteins, for example, Bacillus cereus insecticidal proteins or Ba cillus popl ia e; or Baclilus thuringiensis insecticidal proteins, such as d-endotoxins, for example Cry? A (b), Cry? A (c), CrylF, CryIF (a2), Cry? IA (b), CrylIIA, Cry? IIB (bl) or Cry9c, or vegetative insecticidal proteins (VIP), for example, VIP1, VIP2, VIP3 or VIP3A; or insecticidal proteins from bacteria that colonize nematodes, for example, Photorhabdus spp. or Xenorhabdus spp. , such as Photorhabdus luminescens, Xenorhabdus nema tophilus; toxins produced by animals, such as scorpion toxins, arachnid toxins, wasp toxins and other insect-specific neurotoxins; toxins produced by fungi, such as streptomycete toxins, plant lectins, such as pea lectins, barley lectins or winter chime lectins, agglutinins; proteinase inhibitors, such as trypsin inhibitors, serine protease inhibitors, patatin, cystatin, papain inhibitors; ribosome inactivating proteins (RIP), such as ricin, maize RIP, abrin, lufina, saporin or bryodin; spheroidal metabolism enzymes, such as 3-hydroxysterodeoxydase, ecdysteroid-UDP-glycosyl-transferase, cholesterol oxidases, ecdysone inhibitors, HMG-COA-reductase, ion channel blockers, such as blockers of sodium or calcium channels, esterase the juvenile hormone, diuretic hormone receptors, stilbene synthase, dibenzyl synthase, chitinases and glucanases.

In the context of the present invention, they are to be understood as d-endotoxins, for example, Cry? A (b), Cry? A (c), CrylF, CryIF (a2), Cry? IA (b), CrylIIA, Cry ? IIB (bl) or Cry9c, or vegetative insecticidal proteins (VIP), for example, VIP1, VIP2, VIP3 or VIP3A, also expressly, hybrid toxins, truncated toxins and modified toxins. The hybrid toxins are produced recombinantly by a new combination of domains different from those proteins (see, for example, WO 02/15701). Truncated toxins, for example a truncated Cry? A (b) toxin, are known. In the case of modified toxins, one or more amino acids of the natural toxin are replaced. In said amino acid replacements, protease recognition sequences that are not naturally present are inserted into the toxin, such as, for example, in the case of CryIIIA055, a cathepsin D recognition sequence is inserted into the protein. a CrylIIA toxin (see WO 03/018810). Examples of said toxins or transgenic plants capable of synthesizing such toxins, have been described, for example, in EP-A-0 374 753, WO 93/07278, WO 95/34656, EP-A-0 427 529, EP -A-451 878 and WO 03/052073. The processes for the preparation of said transgenic plants are generally known to those skilled in the art and have been described, for example, in the publications mentioned above. Cryl-type deoxyribonucleic acids and their preparation are known, for example, from WO 95/34656, EP-A-0 367 474, EP-A-0 401 979 and WO 90/13651. The toxin contained in transgenic plants imparts tolerance to harmful insects to plants. These insects can appear in any taxonomic group of insects, but especially they are commonly found in beetles (coleoptera), in insects with two wings (diptera) and in butterflies (lepidoptera). Transgenic plants that contain one or more genes that code for insecticidal resistance and that express one or more toxins are known, and some of them are commercially available. Examples of such plants are: YieldGard® (corn variety expressing a Cry? A (b) toxin); YieldGard Rootworm® (variety of corn that expresses a CrylIIB (bl) toxin); YieldGard Plus® (corn variety that expresses a Cry? Toxin (b) and a CrylIIB toxin (bl)); Starlink® (variety of corn that expresses a Cry9 (c)) toxin; Herculex I® (corn variety that expresses a CryIF toxin (a2) and the enzyme phosphinothricin N-acetyltransferase (PAT) to achieve tolerance to the herbicide glufosinate ammonium); NuCOTN 33B® (cotton variety that expresses a Cry? A (c) toxin; Bollgard I® (cotton variety that expresses a Cry? A (c)) toxin; Bollgard II® (cotton variety that expresses a Cry toxin? A (c) and a Cry? AI (b) toxin; VIPCOT® (cotton variety that expresses a VIP toxin); NewLeaf® (variety of potato expressing a CrylIIA toxin); NatureGard® Agrisure® GT Advantage (GA21 trait) tolerant to glyphosate), Agrisure® CB Advantage (Btll trait of corn plague (CB)) and Protecta® Other examples of such transgenic crops are: 1. Maize Btll of Syngenta Seeds SAS, Chemin de l'Hobit 27, F -31 790 St Sauveur, France, registration number C / FR / 96/05/10, genetically modified Zea mays that has been made resistant to the attack of the European corn plague .. Os trinia nubila lis and Sesamia nonagrioides ) by the transgenic expression of a truncated Cry? A (b) toxin. Corn Btll also transgenically expresses the PAT enzyme to achieve tolerance to the glufosinate ammonium herbicide. 2. Corn Btl76 from Syngenta Seeds SAS, Chemin de l'Hobit 27, F-31 790 St. Sauveur, France, registration number C / FR / 96/05/10. Genetically modified Zea mays that has been made resistant to the European corn pest attack. { Os trinia nubila l is and Sesamia nonagrioides) through the transgenic expression of a Cry? A (b) toxin. The Btl76 corn also transgenically expresses the PAT enzyme to obtain tolerance to the herbicide glufosianto ammonium. 3. Corn MIR604 from Syngenta Seeds SAS, Chemin de l'Hobit 27, F-31 790 St. Sauveur, France, registration number C / FR / 96/05/10. Corn that has been rendered resistant to insects by the transgenic expression of a modified CrylIIA toxin. This toxin is Cry3A055 modified by the insertion of a cathepsin-D-protease recognition sequence. The preparation of said transgenic corn plants has been described in WO 03/018810. 4. Corn MON 863 of Monsanto Europe S.A. 270-272 Avenue de Tervuren, B-1150 Brussels, Belgium, registration number C / DE / 02/9. MON 863 expresses a Cry? IIB toxin (bl) and has resistance to certain coleopteran insects. 5. Cotton IPC 531 of Monsanto Europe S.A. 270-272 Avenue de Tervuren, B-1150 Brussels, Belgium, registration number C / ES / 96/02. 6. Corn 1507 from Pioneer Overseas Corporation, Avenue Tedesco, 7 B-1160 Brussels, Belgium, registration number C / NL / 00/10. The genetically modified corn for the expression of the CrylF protein to achieve resistance to certain lepidopteran insects and the PAT protein to achieve tolerance to the glufosinate ammonium herbicide. 7. Corn NK603 x MON 810 from Monsanto Europe S.A. 270-272 Avenue de Tervuren, B-1150 Brussels, Belgium, registration number C / GB / 02 / M3 / 03. It consists of varieties of hybrid corn conventionally reproduced by crossing the genetically modified varieties NK603 and MON 810. The maize NK603 * MON 810 that transgenically expresses the protein CP4 EPSPS, obtained in Agroba cteri um sp. strain CP4, which imparts tolerance to the Roundup® herbicide (contains glyphosate), and also a Cry? A (b) toxin obtained from Ba cillus thuringiensis subsp. kurstaki that provides tolerance to certain lepidoptera, and includes the European corn plague. Transgenic crops of insect resistant plants have also been described in BATS (Zentrum f? R Biosicherheit und Nachhaltigkeit, Zentrum BATS, Clarastrasse 13, 4058 Basel, Switzerland) Report 2003, (http: //bats.ch). The term "culture" should be interpreted as including also crop plants that have been transformed so that, by the use of recombinant DNA techniques, they are capable of synthesizing antipathogenic substances having selective action, such as, for example, the so-called "proteins". related to pathogenesis "and (PRPs, see for example, EP-A-0 392 225). Examples of said antipathogenic substances and transgenic plants capable of synthesizing said antipathogenic substances are known, for example, from EP-A-0 392 225, WO 95/33818, and EP-A-0 353 191. The methods for producing said plants Transgenic products are generally known to those skilled in the art and have been described, for example, in the publications mentioned above.

Antipathogenic substances that can be expressed by said transgenic plants include, for example, ion channel blockers, such as blockers for sodium and calcium channels, for example, viral KP1, KP4 or KP6 toxins; stilbeno synthases; dibenzyl synthases; chitinases; glucanases; the so-called "proteins related to pathogenesis" (PRPs, see for example, EP-A-0 392 225); antipathogenic substances produced by microorganisms, for example, peptide antibiotics or heterocyclic antibiotics (see for example WO 95/33818) or factors of proteins or polypeptides involved in the protection of plant pathogens (so-called "disease resistance genes"). plants ", as described in WO 03/000906). Other areas of use of the compounds according to the invention are the protection of stored goods and warehouses, and the protection of starting materials such as wood, textiles, coatings for floors or buildings, and also in the hygiene sector, especially for the protection of human beings, domestic animals and productive livestock, against pests of the mentioned type. In the hygiene sector, the compounds according to the invention are active against ectoparasites, such as resistant mites, light mites, mange, harvest mites, flies (choppers and resuscitators), parasitic fly larvae, hair lice, bird lice and fleas. Examples of such parasites are: From the order Anoplurida: Haematopinus spp., Linognathus spp. , Pediculus spp. and Phtirus spp. , Solenopotes spp. From the order Mallophagida: Trimenopon spp., Menopon spp. , Trinoton spp. , Bovicola spp. , Werneckiella spp. , Lepikentron spp. , Damalina spp. , Trichodectes spp. and Felicola spp. From the order of the dipterans and the suborders Nematocerin and Brachycerina, for example, Aedes spp., Anopheles spp. , Culex spp. , Simulium spp. , Eusimulium spp. , Phlebotomus spp. , Lutzomyia spp. , Culicoides spp. , Chrysops spp., Hybomitra spp., Atylotus spp., Tabanus spp., Haematopota spp., Philipomyia spp., Braula spp., Musca spp., Hydrotaea spp., Stomoxys spp., Haematobia spp., Morellia spp. , Fannia spp. , Glossina spp. , Calliphora spp. , Lucilia spp. , Chrysomyia spp. , Wohlfahrtia spp. , Sarcophaga spp. , Oestrus spp. , Hypoderma spp. , Gasterophilus spp. , Hippobosca spp. , Lipoptena spp. and Melophagus spp. From the order of Siphonapterida, for example Pulex spp., Ctenocephalides spp., Xenopsylla spp., Ceratophyllus spp.

Of the order of Heteropterida, for example Cimex spp., Triatoma spp. , Rhodnius spp. , Panstrongylus spp. From the order of Blattarida, for example, Blatta orientalis, Periplaneta americana, Blattelagermanica and Supella spp. From the subclass Acaria (Acarida) and from the orders Meta- and Meso-stigmata, for example Argas spp., Ornithodorus spp. , Otobius spp. , Ixodes spp. , Amblyomma spp. , Boophilus spp. , Dermacentor spp. , Haemophysalis spp. , Hyalomma spp. , Rhipicephalus spp. , Dermanyssus spp. , Raillietia spp. , Pneumonyssus spp., Sternostoma spp. and Varroa spp. Of the orders Actinedida (Prostigmata) and Acaridida (Astigmata), for example, Acarapis spp., Cheyletiella spp., Ornithocheyletia spp., Myobia spp., Psorergatesspp. , Demodex spp. , Trombicula spp. , Listrophorus spp. , Here rus spp. , Tyrophagus spp. , Caloglyphus spp. , Hypodectes spp. , Pterolíchus spp. , Psoroptes spp. , Chorioptes spp. , Otodectes spp. , Sarcoptes spp. , Notoedres spp. , Knemidocoptes spp. , Cytodites spp. and Laminosioptes spp. The compounds according to the invention are also suitable for protecting against insect infestation in the case of materials such as wood, textiles, plastics, adhesives, glues, paints, paper and cardboard, leather, floor coverings and buildings. The invention also relates therefore to pesticidal compositions such as emulsifiable concentrates, suspension concentrates, directly sprayable or dilutable solutions, spreads, diluted emulsions, soluble powders, dispersible powders, wettable powders, granulated powders or encapsulations in polymeric substances, which they comprise - at least - one of the active ingredients according to the invention and which must be selected in order to adapt them to the objectives sought and to the prevailing circumstances. In these compositions, the active ingredient is used in pure form, in the form of an active solid ingredient, for example, in a specific particle size or preferably together, with at least one of the auxiliaries conventionally used in the art of the formulation, such as extenders, for example solvents or solid carriers, or such as surface active compounds (surfactants). Examples of suitable solvents are: unhydrogenated or partially hydrogenated aromatic hydrocarbons, preferably C8 to C? 2 fractions of alkylbenzenes, such as mixtures of xylene, naphthalenes or alkylated tetrahydronaphthalenes, aliphatic or cycloaliphatic hydrocarbons, such as paraffins or cyclohexane, alcohols such as ethanol, propanol or butanol, glycols and their ethers and esters such as propylene glycol, dipropylene glycol ether, ethylene glycol or ethylene glycol monomethyl ether, or ethylene glycol monoethyl ether, ketones, such as cyclohexanone, isophorone, or diacetone alcohol, strongly polar solvents such as N-methylpyrrolid-2-one, dimethyl sulfoxide or N, N-dimethylformamide, water, non-epoxidized or epoxidized vegetable oils, such as rape seed, castor oil, coconut or soybean oils and non-silicone oils. epoxidized or expoxidized. The solid carriers used, for example, for dispersible powders and powders, are, in general, crushed natural minerals such as calcite, talc, kaolin, mont-morillonite or attapulgite. To improve the physical properties, it is also possible to add highly dispersed silicas or highly dispersed absorbent polymers. Adsorbent carriers in particles suitable for granules are of the porous type, such as pumice, brick powder, sepiolite or bentonite, and the appropriate non-sorbent carrier materials are calcite or sand. In addition, a wide variety of granulated materials of inorganic or organic nature, in particular lodomite or waste from crushed plants, can be used. Suitable surface active compounds are, depending on the type of active ingredient to be formulated, surfactants or mixtures of nonionic, cationic and / or anionic surfactants having good emulsifying, dispersing and wetting properties. The surfactants mentioned below should be considered as examples only; a large number of additional surfactants which are conventionally used in the act of formulation and which are suitable in accordance with the invention are described in the relevant literature. Suitable nonionic surfactants are especially polyglycol ether derivatives, of aliphatic or cycloaliphatic alcohols, of saturated or unsaturated fatty acids, or of alkylphenols which may contain about three to about thirty glycol ether groups, and about 8 to about 20 carbon atoms in the hydrocarbon (cyclo) aliphatic radical or about 6 to about 18 carbon atoms in the alkyl portion of the alkylphenols. Also suitable are water-soluble polyethylene oxide adducts, with polypropylene glycol, ethylene diamine polypropylene glycol or alkyl polypropylene glycol having 1 to about 10 carbon atoms in the alkyl chain and about 20 to about 250 ether groups of ethylene glycol and about 10 to about 100 groups of propylene glycol ether. Typically, the aforementioned compounds contain one to about 5 ethylene glycol units per propylene glycol unit. Examples which may be mentioned are nonylphenoxypolyethoxyethanol, polyglycol ether of castor oil, adducts of polypropylene glycol / polyethylene oxide, tributylphenoxypolyethoxyethanol, polyethylene glycol or octylphenoxypolyethoxyethanol. Also, they are suitable fatty acid esters of polyoxyethylene sorbitan, such as polyoxyethylene sorbitan trioleate. The cationic surfactants are, in particular, quaternary ammonium salts which generally have at least one alkyl radical of from about 8 to about 22 C atoms, substituents and as further substituents (non-halogenated or halogenated), alkyl or hydroxyalkyl or benzyl radicals. The salts preferably have the form of halides, methyl sulfates or ethyl sulfates. Examples are stearyltrimethyl ammonium chloride and benzylbis (2-chloroethyl) ethylammonium bromide. Examples of suitable anionic surfactants are water-soluble soaps or synthetic water-soluble surface active compounds. Examples of suitable soaps are alkali metal, alkaline earth or ammonium salts (unsubstituted or substituted), fatty acids having from about 10 to about 22 C atoms such as sodium or potassium salts of oleic or stearic acid, or natural mixtures of fatty acid which are obtainable, for example, from coconut or tallow oil; Fatty acid methyl taurate should also be mentioned. However, synthetic surfactants are used more frequently, in particular fatty sulfonates, fatty sulfates, sulfonated benzimidazole derivatives or alkylaryl sulphonates. In general, fatty sulfonates and fatty sulfates are present as alkali, alkaline-earth, or ammonium salts (substituted or unsubstituted), and in general have an alkyl radical of about 8 to about 22 carbon atoms, and must be taken into account that they include the alkyl portion of acyl radicals; examples which may be mentioned are the sodium or calcium salts of lignosulfonic acid, of the dodecylsulfuric ester or of a mixture of fatty alcohol sulphate prepared from natural fatty acids. The group also includes the salts of sulfuric esters and sulfonic acids of fatty alcohol / ethylene oxide adducts. The sulfonated benzimidazole derivatives preferably contain two sulfonyl groups and a fatty acid radical of from about 8 to about 22 carbon atoms. Examples of alkylaryl sulphonates are the sodium, calcium or triethanolammonium salts of decylbenzenesulfonic acid of dibutylnaphthalenesulfonic acid or of a condensate of naphthalenesulfonic acid and formaldehyde. Likewise, appropriate phosphates are also possible, such as phosphoric ester salts of an adduct of p-nonylphenol / (4-14) ethylene oxide or phospholipids. In general, the compositions comprise 0.1 to 99%, especially 0.1 to 95%, of active ingredient and 1 to 99.9%, especially 5 to 99.9%, of at least one solid or liquid adjuvant, being possible that in general, 0 to 25%, especially 0.1 to 20%, of the composition, consists of surfactants (% in each case means percentage by weight). While concentrated compositions tend to be preferred for commercial goods, the end consumer generally uses dilute compositions, which have substantially lower concentrations of active ingredient. The preferred compositions are composed in particular in the following manner (% = weight percentage): Emulsifiable concentrates: active ingredient: 1 to 95%, preferably, 5 to 20% surfactant: 1 to 30%, preferably, 10 to 20% solvent: 5 to 98%, preferably 70 to 85% Powders active ingredient: 0.1 to 10%, preferably 0.1 to 1% solid carrier: 99.9 to 90%, preferably 99.9 to 99% Suspension Concentrates: active ingredient: 5 to 75%, preferably 10 to 50% water: 94 to 24%, preferably, 88 to 30% surfactant: 1 to 40%, preferably 2 to 30% Wettable powders: active ingredient: 0.5 to 90%, preferably, 1 to 80% surfactant: 0.5 to 20%, preferably, 1 to 15% solid carrier: 5 to 99%, preferably, 15 to 98% Granules: active ingredient: 0.5 to 30%, preferably, 3 to 15% solid carrier: 99.5 to 70%, preferably, 97 to 85% The compositions may also comprise additional solid or liquid auxiliaries such as stabilizers, for example, vegetable oils, non-epoxidized or epoxidized (for example, coconut oil, rapeseed oil, or epoxidized soybean oil), defoamers, for example, silicone oil, preservatives, viscosity regulators, binders and / or adhesives, fertilizers or other active ingredients to achieve specific effects, for example, fungicidal bactericides, nematocides, plant activators, molluscicides or herbicides.

The compositions according to the invention are prepared in a manner known per se in the absence of auxiliaries, for example, by grinding, screening and / or compressing an active solid ingredient and in the presence of at least one auxiliary, for example by intimately mixing and / or grinding the active ingredient with the auxiliary (auxiliaries). These methods for the preparation of the compositions and the use of the compounds I for the preparation of these compositions are also an object of the invention. The methods of application for the compositions, that is, the methods for controlling pests of the aforementioned type, such as for spraying, atomising, dusting, brushing, coating, dispersing or irrigating - which must be selected to suit the objective sought in the circumstances prevalent - and the use of the compositions for controlling the aforementioned type pests are other objects of the invention. Typical concentration regimes are between 0.1 and 1000 ppm, preferably between 0.1 and 500 ppm, of active ingredient. The application rate per hectare is generally from 1 to 2000 g of active ingredient per hectare, in particular 10 to 1000 g / ha, preferably 10 to 600 g / ha. A preferred method of application in the field of crop protection is the application to the foliage of the plants (foliar application), being possible to select the frequency and the application regime to combine it with the danger of infestation of the pest in question. Alternatively, the active ingredient can reach the plant through the root system (systemic action), by irrigating the place where the plants are with a liquid composition, or by incorporating the active ingredient in solid form into the plant site, by example, in the soil, such as, for example, in the form of granules (solid application). In the case of crops in rice fields, these granules can be dosed within the flooded field. The compositions according to the invention are also suitable for the protection of the propagation material of plants, for example, seeds, such as fruits, tubers or grains, or to greenhouse plants, against pests of the aforementioned type. The propagation material can be treated with the compositions before planting it, for example, the seed can be treated before sowing. Alternatively, the compositions may be applied to the seed grains (by coating), either by soaking the grains in a liquid composition, or by applying a layer of a solid composition. It is also possible to apply the compositions when the propagation material is planted at the application site, for example, within the furrow where the seed is deposited during sowing. These treatment methods for the plant propagation material, and the plant propagation material treated in this way, are other objects of the invention.

Preparation Examples Example PI: Preparation of 2- (3-Chloro-pyridin-2-yl) -5-trifluoromethyl 2- (3-chloro-pyridin-2-yl) -5-trifluoromethyl [2- (bicyclopropyl-1-ylcarbamoyl) -4-cyano-6-methyl-phenyl] -amide -2H-pyrazole-3-carboxylic acid (A.1.1): To a solution of 2- [2- (3-chloro-pyridin-2-yl) -5-trifluoromethyl-2H-pyrazol-3-yl] -8-methyl-4-oxo-4H-benzo [d] [1 , 3] oxazine-6-carbonitrile (1.2 g, 2.8 mmol) (prepared with WO 04/067528) in tetrahydrofuran (40 ml), was added bicyclopropyl-1-ylamine hydrochloride (0.6 g, 4.2 mmol ) and 1.2 ml (8.4 mmol) of triethylamine, and the solution was heated to a temperature of 60 ° C for 8 h. The solution was cooled to room temperature and the solvent was evaporated. The mixture was then triturated in 100 ml of water and the crystals were washed with water and ether to give 0.85 g of the title compound. The mother liquor was evaporated and a second crop of crystals was obtained by crystallization from diisopropyl ether to give 0.46 g of the title compound (F: 270-272 ° C).

Example P2: Preparation of 2- (3-Chloro-pyridin-2-yl) -5-trifluoromethyl-2H- [2- (bicyclopropyl-1-ylcarbamoyl) -4-cyano-6-methyl-phenyl] -amide. pyrazole-3-carboxylic acid (A.1.1): To a solution of 3.29 g (5.23 mmol) of 2- (3-chloro-pyridin-2-yl) 2- (bicyclopropyl-1-ylcarbamoyl) -4-iodo-6-methyl-phenyl] -amide. ) -5-trifluoromethyl-2H-pyrazole-3-carboxylic acid in 50 ml of tetrahydrofuran, 1.19 g (6.25 mmoles) of Cul, 0.30 g of tetrakis (triphenylphosphine) palladium and 2.78 g (31.0 mmoles) of CuCN were added. . The mixture was heated for 1 hour at 80 ° C and turned to a dark green color. After cooling, the mixture was filtered over Hyflo and evaporated. The residue was dissolved in 15 ml of DMF and poured into 100 ml of water containing 5 g of NaHC? 3- After 30 minutes of stirring, the crystals were filtered, washed with water and a mixture of hexane / was obtained. acetone (1: 3) to provide 2.8 g of the title compound.

Preparation of 2- (3-Chloro-pyridin-2-yl) -5-trifluoromethyl-2H-pyrazol-2 [2- (bicyclopropyl-1-ylcarbamoyl) -4-iodo-6-methyl-phenyl] -amide. -carboxylic 2. 08 g (3.91 mmol) of (2- [2- (3-chloro-pyridin-2-yl) -5-trifluoromethyl-2H-pyrazol-3-yl] -8-hydroxy-6-iodo-benzo [ d] [1, 3] oxazin-4-one (prepared according to WO 04/067528), 0.6 g (4.50 mmol) of bicyclopropyl-1-ylamine hydrochloride and 0.63 ml (4.50) mmol) of triethylamine in 20 ml of THF were heated for 20 hours under reflux.

After cooling, the precipitate was filtered and the mother liquor was evaporated. The residue is dissolved in 5 ml of DMF and poured into 40 ml of water. The crystals formed are filtered and purified by evaporative chromatography (dichloromethane 40, diethyl ether 1) to give 1.85 g of the title compound. XH-NMR (CDC13, 400 MHz, ppm): 0.11 (q, 2H), 0.45 (q, 2H), 0.62 (s, 4H), 1.4 (m, ÍH), 2.10 (s, 3H), 6.50 (s) , ÍH), 7.40 (m, 2H), 7.51 (s, ÍH), 7.77 (s, ÍH), 7.85 (dd, ÍH), 8.49 (m, ÍH), 10.45 (s, ÍH).

Preparation of 2-Amino-N-bicyclopropyl-l-yl-5-cyano-3-methyl-benzamide 600 mg (1.98 mmol) of 6-iodo-8-methyl-lH-benzo [d] [1,3] oxa zin-2, -dione (prepared according to known procedures, see G. M. Coppola, Syn thesi s, 1980, 505), 212 mg (2.37 mmol) of CuCN, 377 mg (1.98 mmol) of Cul and 114 mg of tetrakis (triphenylphosphine) palladium in 60 ml of THF were heated at reflux for 5 h. After cooling the mixture was filtered over Hyflo. The organic phase was washed with water and evaporated. The residue crystallized from a mixture of dichloromethane, ethyl acetate and hexane to provide 245 mg of 8-methyl-2,4-dioxo-1,4-dihydro-2H-benzo [d] [1,3] oxazine- 6-carbonitrile, which was used directly in the next step. 236 mg (1.16 mmol) of 8-methyl-2,4-dioxo-l, 4-dihydro-2H-benzo [d] [1, 3] oxazine-6-carbonitrile, 234 mg (1.75 mmol) of bicyclopropyl hydrochloride -1-ilamine and 177 mg (1.75 mmol) of triethylamine in 25 ml of THF were heated for 4 h at reflux. The mixture: 1a was cooled _Y_ evaporated. The residue was dissolved in ethyl acetate and extracted with water. After purification in a short passage of silica gel, 63 mg of the title compound was isolated in the form of yellow crystals. F: 171-172 ° C.

Preparation of bicyclopropyl-1-ylamine 93. 2 ml (328 mmol) of Ti (OiPr) 4 were added to a solution of 20 g (298 mmol) of cyclopropane carbonitrile in 300 ml of ether. Then the solution was cooled to -78 ° C and 199 ml (596 mmol) of a solution of ethylmagnesium bromide (3 M in ether) were added slowly. After 10 min at -78 ° C, the suspension was allowed to warm to room temperature and stirred for 1 hour. Then 84.6 g (595 mmol) of BF3.OEt2 were added and the mixture was stirred at room temperature for 18 hours. 600 ml of 2N NaOH were slowly added to this mixture at a temperature of 0 ° C. The organic phase was separated and extracted with 600 ml 2N HCl. The aqueous phase was evaporated and the residue was triturated in ether to give 30.9 g of the title compound as a hydrochloride salt. The following examples are intended to illustrate the invention and show the preferred compounds of the formula I. Me means the methyl group. Et means the ethyl group. If no definition is given for the substituent X then p is 0, if X is a substituent, then p is 1. If no definition is given for substituent A then q is 0, if A is a substituent, then q is 1. The group C (CH2CH2) for the Y substituent means cyclopropyl with two free valencies: Table A: Compounds of formula la Table B: Compounds of formula Ib: Table C: Physical data of the compounds of Tables A and B: Table D: Compounds of formula Va 57 Formulation examples (% = weight percentage) Example Fl: Emulsion concentrates a) b) c) Active ingredient 25% 40% 50% Calcium dodecylbenzenesulfonate 5% 8% 6% Polyethylene glycol ether of castor oil (36 mole of EO) Tributylphenoxy polyethylene glycol ether (30 mole of EO) Cyclohexanone - 15% 20% Mixture of xylene 65% 25% 20% Emulsions of any desired concentration can be prepared from said concentrates by dilution with water.

Example F2: Solutions a) b) c) d) Active ingredient 80% 10% 5% 95% Ethylene glycol monomethyl ether 20% - Polyethylene glycol PM 400 - 70% - N-Methylpyrrolid-2-one - 20% - Oil epoxidized coconut - - 1% 5% Petroleum ether (boiling range: 160-190 °) - The solutions are suitable to be used in the form of microdroplets.

Example F3: Granules a) b) c) d) Active ingredient 5% 10% 8% 21% Kaolin 94% - 79% 54% Highly dispersed silica 1% - 13% 7% Atapulgite - 90% - 18% The active ingredient was dissolved in dichloromethane, the solution was sprayed on the carriers and the solvent was subsequently evaporated in vacuo.

Example F4: Powders a) b) Active ingredient 2% 5% Highly dispersed silica 1% 5% Talc 97% -Caolin - 90% Powders ready for use were obtained by intimately mixing the carriers and the active ingredient.

Example F5: Wettable powders a) b) c) Active ingredient 25% 50% 75% Sodium lignosulfonate 5% 5% Sodium lauryl sulfate 3% - 5% Sodium diisobutylnaphthalene sulfonate - 6% 10% Octylphenoxypolyethylene glycol ether (7 -8 moles of EO) - 2% - Highly dispersed silica 5% 10% 10% Kaolin 62% 27% - The active ingredient was mixed with the additives and the mixture was carefully ground in an appropriate mill. This provided wettable powders, which can be diluted with water to provide suspensions of any desired concentration.

Example F6: Extruded granules Active ingredient 10% Sodium lignosulfonate 2% Carboxymethylcellulose 1% Caolin 87% The active ingredient was mixed with the additives and the mixture was ground, moistened with water, extruded, granulated and dried in a stream of air.

Example F7: Coated granules Active ingredient 3% Polyethylene glycol (PM 200) 3% Caolin 94% In a mixer, the finely ground active ingredient was uniformly applied to the kaolin, which was moistened with the polyethylene glycol. This provided powder-free coated granules.

Example F8: Suspension concentrate Active ingredient 40% Ethylene glycol 10% Nonylphenoxypolyethylene glycol ether (15 mol EO) 10% sodium lignosulfonate 1% carboxymethylcellulose 37% formaldehyde aqueous solution 0.2% Silicone oil (75% aqueous emulsion) Water 32% The finely ground active ingredient was intimately mixed with the additives. Suspensions of any desired concentration can be prepared from the resulting suspension concentrate, by dilution with water.

The activity of the compounds according to the invention can be considerably extended, and can be adapted to the prevailing circumstances, by adding other insecticidally or acaricidally active ingredients. The appropriate additions to the active ingredients given here, for example, are representative of the following classes of active ingredients: organophosphorus compounds, nitrophenol derivatives, nitroureas, juvenile hormones, formamidines, benzophenone derivatives, ureas, pyrrole derivatives, carbamates, pyrethroids, chlorinated hydrocarbons, acylureas, pyridyl-methyleneamino derivatives, macrolides, neonicotinoids and preparations of Bacillus thuringiensis. The following mixtures of the compounds of formula I with active ingredients are preferred (the abbreviation "TX" means "a compound selected from the group consisting of the compounds specifically described in Tables A and B of the present invention"): an adjuvant selected from group of substances consisting of petroleum oils (alternative name) (628) + TX, an acaricide selected from the group of substances consisting of: 1, 1-bis (4-chlorophenyl) -2-ethoxyethanol (IUPAC name) ( 910) + TX, 2,4-dichlorophenyl benzenesulfonate (name of IUPAC / Chemical Abstracts) (1059) + TX, 2 -f luor-N-methyl-? J-1-naphthylacetamide (IUPAC name) (1295) + TX, 4-chlorophenyl phenyl sulfone (IUPAC name) (981) + TX, abamectin (1) + TX, acequinocyl (3) + TX, acetoprol [CCN] + TX, acrinathrin (9) + TX, aldicarb (16) + TX, aldoxicarb (863) + TX, alpha- cypermethrin (202) + TX, amidition (870) + TX, amidoflumet [CCN] + TX, amidothioate (872) + TX, amiton (875) + TX, amiton hydrogen oxalate (875) + TX, amitraz (24) + TX , aramite (881) + TX, arsenious oxide (882) + TX, AVI 382 (compound code) + TX, AZ 60541 (compound code) + TX, azinphos-ethyl (44) + TX, azinphos-methyl (45 ) + TX, azobenzene (IUPAC name) (888) + TX, azocyclotin (46) + TX, azotoate (889) + TX, benomyl (62) + TX, benoxafos (alternative name) [CCN] + TX, benzoximate ( 71) + TX, benzyl benzoate (IUPAC name) [CCN] + TX, bifenazate (74) + TX, bifenthrin (76) + TX, binapacril (907) + TX, brofenvalerate (alternative name) + TX, bromcycle n (918) + TX, bromophos (920) + TX, bromophos-ethyl (921) + TX, bromopropylate (94) + TX, buprofezin (99) + TX, butocarboxim (103) + TX, butoxicarboxim (104) + TX , butylpyridaben (alternative name) + TX, calcium polysulfide (IUPAC name) (111) + TX, camfeclor (941) + TX, carbanolate (943) + TX, carbaryl (115) + TX, carbofuran (118) + TX , carbofenotion (947) + TX, CGA 50 '439 (developed code) (125) + TX, quinometionat (126) + TX, chlorbenside (959) + TX, clordimeform (964) + TX, chlorodimeform hydrochloride (964) + TX, chlorfenapyr (130) + TX, chlorphenethol (968) + TX, chlorfenson (970) + TX, chlorfensulfide (971) + TX, chlorfenvinphos (131) + TX, chlorobenzilate (975) + TX, chloromebuform (977) + TX , chloromethyuron (978) + TX, chloropropylate (983) + TX, chlorpyrifos (145) + TX, chlorpyrifos-methyl (146) + TX, chlortiofos (994) + TX, cinerin I (696) + TX, cinerin II (696 ) + TX, cinerins (696) + TX, clofentezine (158) + TX, closantel (alternative name) [CCN] + TX, coumaphos (174) + TX, crotamiton (alternate name) [CCN] + TX, crotoxifos (1010) + TX, cufraneb (1013) + TX, cyanoate (1020) + TX, cyhalothrin (196) + TX, cyhexatin (199) + TX, cypermethrin (201) + TX, DCPM (1032) + TX, DDT (219) + TX, demephion (1037) + TX, demephion-0 (1037) + TX, demephion-S (1037) + TX, demeton (1038) + TX, demeton-methyl (224) + TX, demeton-0 (1038) + TX , demeton-O-methyl (224) + TX, demeton-S (1038) + TX, demeton-S-methyl (224) + TX, demeton-S-methylsulfon (1039) + TX, diafentiuron (226) + TX, dialiphos (1042) + TX, diazinon (227) + TX, diclofluanid (230) + TX, dichlorvos (236) + TX, diclifos (alternative name) + TX, dicofol (242) + TX, dicrotophos (243) + TX, dienoclor (1071) + TX, dimefox (1081) + TX, dimethoate (262) + TX, dinactin (alternative name) (653) + TX, dinex (1089) + TX, dinex-diclexine (1089) + TX, dinobuton ( 269) + TX, dinocap (270) + TX, dinocap-4 [CCN] + TX, dinocap-6 [CCN] + TX, dinocton (1090) + TX, dinopentone (1092) + TX, dinosulfon (1097) + TX , dinoterbon (1098) + TX, dioxation (1102) + TX, diphenyl sulfone (IUPAC name) (1103) + TX, disulfiram (alternative name) [CCN] + TX, disulfoton (278) + TX, DNOC (282) + TX, dofenapin (1113) + TX, doramectin (alternative name) [CCN] + TX, endosulfan (294) + TX, endotion (1121) + TX, EPN (297) + TX, eprinomectin (alternative name) [CCN] + TX, etion (309) + TX, ethoate-methyl (1134) ) + TX, ethoxazole (320) + TX, etrimphos (1142) + TX, fenazaflor (1147) + TX, fenazaquin (328) + TX, fenbutatin oxide (330) + TX, phenothiocarb (337) + TX, fenpropathrin ( 342) + TX, fenpirad (alternative name) + TX, fenpyroximate (345) + TX, fenson (1157) + TX, phentrifanil (1161) + TX, fenvalerate (349) + TX, fipronil (354) + TX, fluacripirim ( 360) + TX, fluazuron (1166) + TX, flubenzimine (1167) + TX, flucycloxuron (366) + TX, flucythrinate (367) + TX, fluenethyl (1169) + TX, flufenoxuron (370) + TX, flumethrin (372) ) + TX, fluorbenside (1174) + TX, fluvalinate (1184) + TX, FMC 1137 (developed code) (1185) + TX, formetanate (405) + TX, formetanate hydrochloride (405) + TX, formothion (1192) + TX, formparanate (1193) + TX, gamma-HCH (430) + TX, gliodin (1205) + TX, halfenprox (424) + TX, heptenophos (432) + TX, cyclopropancarbox hexadecyl ilate (name of IUPAC / Chemical Abstracts) (1216) + TX, hexitiazox (441) + TX, iodomethane (IUPAC name) (542) + TX, isocarbophos (alternative name) (473) + TX, O- ( methoxy-aminothiophosphoryl) isopropyl salicylate (IUPAC name) (473) + TX, ivermectin (alternate name) [CCN] + TX, jasmolin I (696) + TX, jasmolin II (696) + TX, jodfenfos (1248) + TX, lindane (430) + TX, lufenuron (490) + TX, malathion (492) + TX, malonoben (1254) + TX, mecarbam (502) + TX, mephospholan (1261) + TX, mesulfen ( alternate name) [CCN] + TX, methacryphs (1266) + TX, methamidophos (527) + TX, metidation (529) + TX, methiocarb (530) + TX, methomyl (531) + TX, methyl bromide (537) + TX, metolcarb (550) + TX, mevinfos (556) + TX, mexacarbate (1290) + TX, milbemectin (557) + TX, milbemycin oxime (alternative name) [CCN] + TX, mipafox (1293) + TX, monocrotophos (561) + TX, morphothion (1300) + TX, moxidectin (alternative name) [CCN] + TX, naled (567) + TX, NC-184 (compound code) + TX, nifluridide (1309) + TX, nikkomicins (alternative name) [CCN] + TX, nitrilacarb (1313) + TX, nitrilacarb 1: 1 zinc chloride complex (1313) + TX, NNI-0101 (compound code) + TX, NNI-0250 (code of compound) + TX, ometoate (594) + TX, oxamyl (602) + TX, oxideprofos (1324) + TX, oxidisulfoton (1325) + TX, pp '-DDT (219) + TX, paration (615) + TX, permethrin (626) + TX, petroleum oils (alternative name) (628) + TX, fenkapton (1330) + TX, phenoate (631) + TX, phorate (636) + TX, fosalone (637) + TX, phospholan (1338) + TX, fosmet (638) + TX, phosphamidon (639) + TX, phoxim (642) + TX, pirimiphos-methyl (652) + TX, polychloro-terpenes (traditional name) (1347) + TX, polinactins (alternative name) (653) + TX, proclonol (1350) + TX, profenofos (662) + TX, promacil (1354) + TX, propargite (671) + TX, propetamfos (673) + TX, propoxur (678) + TX, protidation (1360) + TX, protoate (1362) + TX, pyrethrin I (696) + TX, pyrethrin II (696) + TX, pyrethrins (696) + TX, pyridaben (699) + TX, pyridafention (701) ) + TX, pyrimidifen (706) + TX, pyrimitate (1370) + TX, quinalphos (711) + TX, quintiofos (1381) + TX, R-1492 (code in development) (1382) + TX, RA-17 ( code under development) (1383) + TX, rotenone (722) + TX, escradan (1389) + TX, sebufos (alternative name) + TX, selamectin (alternate name) [CCN] + TX, SI-0009 (code d) e compound) + TX, sofamide (1402) + TX, spirodiclofen (738) + TX, spiromesifen (739) + TX, SSI-121 (code under development) (1404) + TX, sulfiram (alternative name) [CCN] + TX, sulfluramid (750); sulfotep (753); sulfur (754) + TX, SZI-121 (code under development) (757) + TX, tau-fluvalinate (398) + TX, tebufenpirad (763) + TX, TEPP (1417) + TX, terbam (alternative name) + TX, tetrachloro vinphos (777) + TX, tetradifon (786) + TX, tetranactin (alternative name) (653) + TX, tetrasul (1425) + TX, thia-phenox (alternative name) + TX, thiocarboxim (1431) + TX, thiofanox (800) + TX, thiometon (801) + TX, thioquinox (1436) + TX, thuringiensin (alternative name) [CCN] + TX, triamiphos (1441) + TX, triaratene (1443) + TX, triazophos (820) + TX, triazuron (alternative name) + TX, trichlorfon (824) + TX, triphenophos (1455) + TX, trinactin (alternative name) (653) + TX, vamidothion (847) + TX, vaniliprol [CCN] and YI-5302 (compound code) + TX, an algicide selected from the group of substances consisting of betoxazine [CCN] + TX, copper dioctanoate (IUPAC name) (170) + TX, copper sulfate (172) + TX, cibutrin [CCN] + TX, diclone (1052) + TX, dichlorophen (232) + TX, endotal (295) + TX, fenti na (347) + TX, hydrated lime [CCN] + TX, nabam (566) + TX, quinoclamine (714) + TX, quinonamid (1379) + TX, simazine (730) + TX, triphenyltin acetate (IUPAC name) ) (347) and triphenyltin hydroxide (IUPAC name) (347) + TX, an anthelmintic selected from the group consisting of abamectin (1) + TX, crufomate (1011) + TX, doramectin (alternative name) [CCN] ] + TX, emamectin (291) + TX, emamectin benzoate (291) + TX, eprinomectin (alternative name) [CCN] + TX, ivermectin (alternative name) [CCN] + TX, milbemycin oxime (alternative name) [CCN] ] + TX, moxidectin (alternative name) [CCN] + TX, piperazine [CCN] + TX, selamectin (alternative name) [CCN] + TX, spinosad (737) and, thiophanate (1435) + TX, an avicide selected from the group of substances consisting of chloralose (127) + TX, endrin (1122) + TX, fention (346) + TX, pyridin-4-amine (name of IUPAC) (23) and strychnine (745) + TX, a bactericide selected from the group of substances consisting of l-hydroxy-lyr-pyridine-2-thione (IUPAC name) (1222) + TX, 4- (quinoxalin-2-ylamino) benzenesulfonamide (IUPAC name) (748) + TX, 8-hydroxyquinoline sulfate (446) + TX, bronopol (97) + TX, copper dioctanoate (IUPAC name) (170) + TX , copper hydroxide (IUPAC name) (169) + TX, cresol [CCN] + TX, dichlorophen (232) + TX, dipyrithione (1105) + TX, dodycin (1112) + TX, fenaminosulf (1144) + TX, formaldehyde (404) + TX, hydrargafen (alternative name) [CCN] + TX, kasugamycin (483) + TX, kasugamycin dihydrochloride (483) + TX, nickel bis (dimethyldithiocarbamate) (IUPAC name) (1308) + TX , nitrapyrin (580) + TX, octylinone (590) + TX, oxolinic acid or (606) + TX, oxytetracycline (611) + TX, potassium hydroxyquinoline sulfate (446) + TX, probenazole (658) + TX, streptomycin (744) + TX, streptomycin sesquisulfate (744) + TX, tecloftalam (766) and thiomersal (alternative name) [CCN] + TX, a biological agent selected from the group consisting of Adoxophyes orana GV (alternative name) (12) + TX, Agroba cteri um radioba cter (alternate name) (13) + TX, Amblysei us spp . (alternative name) (19) + TX, Anagrapha fal cifera NPV (alternative name) (28) + TX, Anagrus a tomus (alternative name) (29) + TX, Aphelinus abdominal is (alternative name) (33) + TX, Aphidi us colemani (alternative name) (34) + TX, Aphidoletes aphidimyza (alternative name) (35) + TX, Autographa californi ca NPV (alternative name) (38) + TX, Ba cill us firmus (alternative name) (48) + TX, Bacillus sphaericus Neide (scientific name) (49) + TX, Bacillus thuringiensis Berliner (scientific name) (51) + TX, Bacillus thuringiensis subsp. aizawai (scientific name) (51) + TX, Bacillus thuringiensis subsp. israelensis (scientific name) (51) + TX, Bacillus thuringiensis subsp. japonensis (scientific name) (51) + TX, Bacillus thuringiensis subsp. kurstaki (scientific name) (51) + TX, Bacillus thuringiensis subsp. tenebrionis (scientific name) (51) + TX, Beauveria bassiana (alternative name) (53) + TX, Beauveria brongniartii (alternative name) (54) + TX, Chrysoperla carnea (alternate name) (151) + TX, Cryptolaemus montrouzieri ( alternative name) (178) + TX, Cydia pomonella GV (alternative name) (191) + TX, Dacnusa sibirica (alternative name) (212) + TX, Diglyphus isaea (alternate name) (254) + TX, Encarsia formosa (name scientific) (293) + TX, Eretmocerus eremicus (alternate name) (300) + TX, Helicoverpa zea NPV (alternate name) (431) + TX, Heterorhabditis bacteriophora and H. megidis (alternate name) (433) + TX, Hippodamia convergens (alternative name) (442) + TX, Leptomastix dactylopii (alternative name) (488) + TX, Macrolophus caligínosus (alternative name) (491) + TX, Mamestra brassicae NPV (alternative name) (494) + TX, Metaphycus helvolus (alternative name) (522) + TX, Metarhizium anisopliae var. acridum (scientific name) (523) + TX, Metarhi zi um ani soplia e var. ani sopl ia e (scientific name) (523) + TX, Neodiprion sertifer NPV and N. lecontei NPV (alternative name) (575) + TX, Ori us spp. (alternate name) (596) + TX, Paecilomyces fumosoroseus (alternate name) (613) + TX, Phytosei ul us persimilis (alternate name) (644) + TX, Spodoptera exigua multi-capsid nuclear polyhedrosis virus (scientific name) (741 ) + TX, Steinernema bibioni s (alternative name) (742) + TX, Steinernema carpocapsae (alternative name) (742) + TX, Steinernema fel tiae (alternative name) (742) + TX, Steinernema glaseri (alternative name) (742) ) + TX, Steinernema riobra ve (alternative name) (742) + TX, Steinernema riobra vi s (alternative name) (742) + TX, Steinernema scapteri sci (alternative name) (742) + TX, Steinernema spp. (alternative name) (742) + TX, Trichogramma spp. (alternative name) (826) + TX, Typhlodromus occiden ta lis (alternative name) (844) and Verticill i um lecanií (alternative name) (848) + TX, a soil sterilizer selected from the group of substances consisting of iodomethane (name of IUPAC) (542) and methyl bromide (537) + TX, a chemosterilizer selected from the group of substances consisting of afolate [CCN] + TX, bisazir (alternative name) [CCN] + TX, busulfan (alternative name) ) [CCN] + TX, diflubenzuron (250) + TX, dimatif (alternative name) [CCN] + TX, hemel [CCN] + TX, hempa [CCN] + TX, metepa [CCN] + TX, metiotepa [CCN] + TX, methyl afolate [CCN] + TX, morzid [CCN] + TX, penfluron (alternative name) [CCN] + TX, tepa [CCN] + TX, tiohempa (alternative name) [CCN] + TX, thiotepa ( alternative name) [CCN] + TX, tretamine (alternative name) [CCN and uredepa (alternative name) [CCN] + TX, an insect pheromone selected from the group of substances consisting of acetate. { E) -dec-5-en-l-yl with (£) -dec-5-en-l-ol (IUPAC name) (222) + TX, acetate . { E) -tridec-4-en-l-yl (IUPAC name) (829) + TX, (£) -6-methylhept-2-en-4-ol (IUPAC name) (541) + TX, acetate from . { E, Z) -tetradeca-4, 10-dien-l-yl (IUPAC name) (779) + TX, (Z) -dodec-7-en-l-yl acetate (IUPAC name) (285) + TX, (Z) -hexadec-11-enal (IUPAC name) (436) + TX, (Z) -hexadec-11-en-l-yl acetate (IUPAC name) (437) + TX, acetate of (Z) -hexadec-13-en-ll-in-l-yl (IUPAC name) (438) + TX, (Z) -icos-13-en-10-one (IUPAC name) (448) + TX, (Z) -tetradec-7-en-l-al (name of IUPAC) (782) + TX, (Z) -tetra-dec-9-en-l-ol (name of IUPAC) (783) + TX, (Z) -tetradec-9-en-l-yl acetate (IUPAC name) (784) + TX, (7 £, 9Z) -dodeca-7, 9-dien-l-yl acetate ( name of IUPAC) (283) + TX, acetate (9Z, 11 £) -tetradeca-9, 11-dien-l-ilo (IUPAC name) (780) + TX, acetate (9Z, 12 £) - tetradeca-9, 12-dien-l-yl (IUPAC name) (781) + TX, 14-methyloctadec-l-ene (IUPAC name) (545) + TX, 4-methylnonan-5-ol with 4- methyl-nonan-5-one (IUPAC name) (544) + TX, alpha-multistriatin (alternate name) [CCN] + TX, brevicomin (alternative name) [CCN] + TX, codlelure (alternative name) [CCN] + TX, codlemone (alternative name) (167) + TX, cuelure (alternative name) (179) + TX, disparlure (277) + TX, dodec-8-en-l-yl acetate (IUPAC name) (286) + TX, dodec-9-en-l-yl acetate (name of IUPAC) (287) + TX, dodeca-8 acetate, 10-dien-l-yl (IUPAC name) (284) + TX, dominicalure (alternative name) [CCN] + TX, 4-methyloctanoate ethyl (IUPAC name) (317) + TX, eugenol (alternative name) [CCN] + TX, frontalina (alternative name) [CCN] + TX, gossyplure (alternative name) (420) + TX, grandlure (421) + TX, grandlure I (alternative name) (421) + TX, grandlure II (alternative name) (421) + TX, grandlure III (alternate name) (421) + TX, grandlure IV (alternative name) (421) + TX, hexalure [CCN] + TX, ipsdienol (alternative name) [CCN] + TX, ipsenol ( alternative name) [CCN] + TX, japonilure (alternative name) (481) + TX, lineatin (alternate name) [CCN] + TX, litlure (alternative name) [CCN] + TX, looplure (alternative name) [CCN] + TX, medlure [CCN] + TX, megatomoic acid (alternative name) [CCN] + TX, methyl eugenol (alternative name) (540) + TX, muscalure (563) + TX, octadeca-2 acetate, 13-dien-l-yl (IUPAC name) (588) + TX, octadeca-3, 13-dien acetate -l-ilo (name of IUPAC) (589) + TX, orfralure (alternative name) [CCN] + TX, orictalure (alternative name) (317) + TX, ostramona (alternate name) [CCN] + TX, siglure [ CCN] + TX, sordidin (alternative name) (736) + TX, sulcatol (alternative name) [CCN] + TX, tetradec-11-en-l-yl acetate (IUPAC name) (785) + TX, trimedlure (839) + TX, trimedlure A (alternative name) (839) + TX, trimedlure Bi (alternate name) (839) + TX, trimedlure B2 (alternative name) (839) + TX, trimedlure C (alternative name) (839) ) and trunc-call (alternate name) [CCN] + TX, an insect repellent selected from the group consisting of 2- (octylthio) ethanol (IUPAC name) (591) + TX, butopironoxyl (933) + TX , butoxy (polypropylene glycol) (936) + TX, dibutyl adipate (IUPAC name) (1046) + TX, dibut phthalate ilo (1047) + TX, dibutyl succinate (IUPAC name) (1048) + TX, diethyltoluamide [CCN] + TX, dimethyl carbamate [CCN] + TX, dimethyl phthalate [CCN] + TX, ethyl hexanediol (1137) ) + TX, hexamide [CCN] + TX, methoquin-butyl (1276) + TX, methyl-decanamide [CCN] + TX, oxamate [CCN] and picaridin [CCN] + TX, an insecticide selected from the group of substances consisting of 1+ TX, 1, 1-dichloro-l-nitroethane (name IUPAC- / Chemical Abstracts) (1058) + TX, 1, 1-dichloro-2, 2-bis (4-ethylphenyl) ethane (IUPAC name) (1056) + TX, 1,2-dichloropropane (IUPAC- / Chemical Abstracts-Name) (1062) + TX, 1,2-dichloropropane with 1,3-dichloropropene (IUPAC name) (1063) + TX, l-bromo-2-chloroethane (name IUPAC- / Chemical Abstracts) (916) + TX, 2, 2, 2-trichloro-l- (3,4-dichlorophenyl) ethyl acetate (IUPAC name) (1451) + TX, 2,2-dichlorovinyl 2-ethylsulfinylethyl methyl phosphate (IUPAC name) ( 1066) + TX, 2- (1, 3-dithiolan-2-yl) phenyl dimethylcarbamate (IUPAC- / Chemical Abstracts-Name) (1109) + TX, 2- (2-butoxyethoxy) ethyl thiocyanate (IUPAC name / Chemical Abstracts) (935) + TX, 2- (4,5-dimethyl-1,3-dioxolan-2-yl) phenyl methylcarbamate (name of IUPAC / Chemical Abstracts) (1084) + TX, 2- (4-chloro-3, 5-xylyloxy) ethanol (name of IUPAC) (986) + TX, 2-chlorovinyl diethyl phosphate (name of IUPAC) (984) + TX, 2-imidazolidone (IUPAC name) (1225) + TX, 2-isovalerylinddan-1, 3-dione (IUPAC name) (1246) + TX, 2-methyl methylcarbamate (prop-2-ynyl) aminophenyl (IUPAC name) (1284) + TX, 2-thiocyanatoethyl laurate (IUPAC name) (1433) + TX, 3-bromo-l-chloroprop-1-ene (IUPAC name) ) (917) + TX, 3-methyl-1-phenylpyrazol-5-yl dimethylcarbamate (IUPAC name) (1283) + TX, 4-methyl (prop-2-ynyl) amino-3,5-xylyl methylcarbamate (IUPAC name) (1285) + TX, 5,5-dimethyl-3-oxocyclohex-l-enyl dimethylcarbamate (IUPAC name) (1085) + TX, abamectin (1) + TX, acephate (2) + TX , acetamiprid (4) + TX, acetion (alternative name) [CCN] + TX, acetoprol [CCN] + TX, acrinatrin (9) + TX, acrylonitrile (IUPAC name) (861) + TX, alanicarb (15) + TX, aldicarb (16) + TX, aldoxicarb (863) + TX, aldrin (864) + TX, allethrin (17) + TX, alosamidine (alternative name) [CCN] + TX, alixicarb (866) + TX, alpha- cypermethrin (202) + TX, alpha-ecdysone (name) e) [CCN] + TX, aluminum phosphide (640) + TX, amidition (870) + TX, amidothioate (872) + TX, aminocarb (873) + TX, amiton (875) + TX, amiton hydrogen oxalate ( 875) + TX, amitraz (24) + TX, anabasine (877) + TX, atidation (883) + TX, AVI 382 (compound code) + TX, AZ 60541 (compound code) + TX, azadirachtin (alternative name) ) (41) + TX, azamethiphos (42) + TX, azinphos-ethyl (44) + TX, azinphos-methyl (45) + TX, azotoate (889) + TX, Ba cill us thuringi ensis delta endotoxins (alternative name) (52) + TX, barium hexafluorosilicate (alternative name) [CCN] + TX, barium polysulfur (IUPAC- / Chemical Abstracts-Name) (892) + TX, bartrina [CCN] + TX, BAS 320 I (compound code) + TX, Bayer 22/190 (code under development) (893) + TX, Bayer 22408 (code under development) (894) + TX, bendiocarb (58) + TX, benfuracarb (60) + TX, bensultap (66) + TX, beta-cyfluthrin (194) + TX, beta-cypermethrin (203) + TX, bifenthrin (76) + TX, bioallethrin (78) + TX, bioallethrin S-cyclopentenyl isomer (alternative name) (79) + TX, bioetanometrine [CCN] + TX, biopermethrin (908) + TX, bioresmethrin (80) + TX, bis (2-chloroethyl) ether ( name of lUPAC) (909) + TX, bistrifluron (83) + TX, borax (86) + TX, brofenvalerate (alternative name) + TX, bromfenvinphos (914) + TX, bromocycline (918) + TX, bromo-DDT (alternative name) [CCN] + TX, bromophos (920) + TX, bromophos-ethyl (921) + TX, bufencarb (924) + TX, buprofezin (99) + TX, butacarb (926) + TX, butathiophos (927) + TX, butocarboxim (103) + TX, butonato (932) + TX, butoxycarboxim (104) + TX, butylpyridaben (alternative name) + TX, cadusafos (109) + TX, calcium arsenate [CCN] + TX, calcium cyanide (444) + TX, calcium polysulfide ( name of lUPAC) (111) + TX, camfeclor (941) + TX, carbanolato (943) + TX, carbaryl (115) + TX, carbofuran (118) + TX, carbon disulfide (name of UPAC / Chemical Abstracts) (945) + TX, carbon tetrachloride (IUPAC name) (946) + TX, carbofenothion (947) + TX, carbosulfan (119) + TX, cartap (123) + TX, cartap clorhirate (123) + TX, cevadine (alternative name) (725) + TX, clorbiciclen (960) + TX, chlordane (128) + TX, chlordecone (963) + TX, clordimeform (964) + TX, clordimeform hydrochloride (964) + TX, chloretoxyphos (129) + TX, chlorfenapyr (130) + TX, chlorfen-vinphos (131) + TX, chlorfluazuron (132) + TX, chlorormephos (136) + TX, chloroform [CCN] + TX, chloropicrin (141) + TX, chlorphoxim (989) + TX, chlorprazophos (990) + TX , chlorpyrifos (145) + TX, chlorpyrifos-methyl (146) + TX, clortiofos (994) + TX, chromafenozide (150) + TX, cinerin I (696) + TX, cinerin II (696) + TX, cinerins (696 ) + TX, cis-resmethrin (alternative name) + TX, cismethrin (80) + TX, clocitrin (alternative name) + TX, cloetocarb (999) + TX, closantel (alternative name) [CCN] + TX, clothianidin (165 ) + TX, copper acetoarsenite [CCN] + TX, copper arsenate [CCN] + TX, copper oleate [CCN] + TX, coumaphos (174) + TX, coumitoate (1006) + TX, crotamiton (alternative name) [CCN] + TX, crotoxifos (1010) + TX , crufomato (1011) + TX, cryolite (alternative name) (177) + TX, CS 708 (code under development) (1012) + TX, cyanofenfos (1019) + TX, cyanophos (184) + TX, cyantoate (1020) + TX, cyclinthrin [CCN] + TX, cycloprothromine (188) + TX, cyfluthrin (193) + TX, cyhalothrin (196) + TX, cypermethrin (201) + TX, cyphenothrin (206) + TX, cyromazine (209) + TX, cytoate (alternative name) [CCN] + TX, d-limonene (alternative name) [CCN] + TX, -tetramethrin (alternative name) (788) + TX, DAEP (1031) + TX, dazomet (216) + TX, DDT (219) + TX, decarbofuran (1034) + TX, deltamethrin (223) + TX, demephion (1037) + TX, demephion-0 (1037) + TX, demephion-S (1037) + TX, demeton ( 1038) + TX, demeton-methyl (224) + TX, demeton-0 (1038) + TX, demeton-O-methyl (224) + TX, demeton-S (1038) + TX, demeton-S-methyl (224) + TX, demeton-S-methylsulfon (1039) + TX, diafentiuron (226) + TX, dialiphos (1042) + TX, diamidaphos (1044) + TX, diazinon (227) + TX, dicapton (1050) + TX, diclofention (1051) + TX, dichlorvos (236) + TX, dicliphos ( alternative name) + TX, dicresyl (alternative name) [CCN] + TX, dicrotophos (243) + TX, dicyclanil (244) + TX, dieldrin (1070) + TX, diethyl 5-methylpyrazol-3-yl phosphate (name of IUPAC) (1076) + TX, diflubenzuron (250) + TX, dilor (alternative name) [CCN] + TX, dimefluthrin [CCN] + TX, dimefox (1081) + TX, dimethane (1085) + TX, dimethoate (262) + TX, dimetrin (1083) + TX, dimethylvinphos (265) + TX, dimethylated (1086) + TX, dinex (1089) + TX, dinex-diclexine (1089) + TX, dinoprop (1093) + TX, dinosam (1094) + TX, dinoseb (1095) + TX, dinotefuran (271) + TX, diofenolan (1099) + TX, dioxabenzofos (1100) + TX, dioxacarb (1101) + TX, dioxation (1102) + TX, disulfoton (278) + TX, dithicrophos (1108) + TX, DNOC (282) + TX, doramectin (alternate name) [CCN] + TX, DSP (1115) + TX, ecdisterone (alternative name) [CCN] + TX, El 1642 (code under development) (1118) + TX, emamectin (291) + TX, benzoate emamectin (291) + TX, EMPC (1120) + TX, empentrin (292) + TX, endosulfan (294) + TX, endotion (1121) + TX, endrin (1122) + TX, EPBP (1123) + TX, EPN (297) + TX, epofenonane (1124) + TX, eprinomectin (alternative name) [CCN] + TX, esfenvalerate (302) + TX, ethaphos (alternative name) [CCN] + TX, etiofencarb (308) + TX, etion (309) + TX, etiprole (310) + TX, ethoate-methyl (1134) + TX, ethoprofos (312) + TX, ethyl formate (IUPAC name) [CCN] + TX, ethyl-DDD (alternative name) (1056) + TX, ethylene dibromide (316) + TX, ethylene dichloride (chemical Name) (1136) + TX, ethylene oxide [CCN] + TX, etofenprox (319) + TX, etrimphos (1142) + TX, EXD (1143) + TX, famfur (323) + TX, fenamiphos (326) + TX, fenazaflor (1147) + TX, phentochlor (1148) + TX, phenetacarb (1149) + TX, fenfluthrin (1150) + TX, fenitrothion (335) + TX, phenobucarb (336) + TX, fenoxacrim (1153) + TX, phenoxycarb (340) + TX, fenpiritrin (1155) + TX, fenpropathrin (342) + TX, fenpyrad (alternative name) + TX, fensulfotion (1158) + TX, fention (346) + TX, fenthion-ethyl [CCN] + TX, fenvalerate (349) + TX, fipronil (354) + TX, flonicamid (358) + TX, flucofuron (1168) + TX, flucycloxuron (366) + TX, flucitrinate (367) + TX, fluenethyl (1169) + TX, flufenerim [CCN] + TX, flufenoxuron (370) + TX, flufenprox (1171) + TX, flumethrin (372) + TX, fluvalinate (1184) + TX, FMC 1137 (code under development) (1185) + TX, fonophos (1191) + TX, formetanate (405) + TX, formetanate hydrochloride (405) + TX, formothion (1192) + TX, formparanate (1193) + TX, fosmetilan (1194) + TX, phosphate (1195) + TX, fosthiazate (408) + TX, fostietan (1196) + TX, furathiocarb (412) + TX, furethrin (1200) + TX, gamma-cyhalothrin (197) + TX, gamma-HCH (430) + TX, guazatine (422) + TX, guazatin acetate (422) + TX, GY-81 (code under development) (423) + TX, halfenprox (424) + TX, halofenozide (425) + TX, HCH (430) + TX, HEOD (1070) + TX, heptachlor (1211) + TX, heptenophos (432) + TX, heterophos [CCN] + TX, hexaflumuron (439) + TX, HHDN (864) + TX, hydramethylnon (443 ) + TX, hydrogen cyanide (444) + TX, hydroprene (445) + TX, hiquincarb (1223) + TX, imidacloprid (458) + TX, imiprotrin (460) + TX, indoxacarb (465) + TX, IPSP ( 1229) + TX, isazophos (1231) + TX, isobenzan (1232) + TX, isocarbophos (alternative name) (473) + TX, isodrine (1235) + TX, isofenfos (1236) + TX, isolano (1237) + TX , isoprocarb (472) + TX, isopropyl O- (methoxyminothiophosphoryl) salicylate (IUPAC name) (473) + TX, isoprothiolane (474) + TX, isothioate (1244) + TX, isoxation (480) + TX, ivermectin (name alternative) [CCN] + TX, jasmolin I (696) + TX, jasmolin II (696) + TX, jodfenfos (1248) + TX, juvenile hormone I (alternative name) [CCN] + TX, juvenile hormone II (alternative name) ) [CCN] + TX, juvenile hormone III (alternate name) [CCN] + TX, kelevan (1249) + TX, kinoprene (484) + TX, lambda-cyhalothrin (198) + TX, lead arsenate [CCN] + TX, leptophos (1250) + TX, lindane (430) + TX, lyrimphos (1251) + TX, lufenuron (490) + TX, litidation (1253) ) + TX, m-cumenyl methylcarbamate (IUPAC name) (1014) + TX, magnesium phosphide (IUPAC name) (640) + TX, malathion (492) + TX, malonoben (1254) + TX, mazidox ( 1255) + TX, mecarbam (502) + TX, mecarphone (1258) + TX, menazon (1260) + TX, mephospholan (1261) + TX, mercury chloride (513) + TX, mesulfenphos (1263) + TX, metam ( 519) + TX, metam-potassium (alternative name) (519) + TX, metam-sodium (519) + TX, methacryphs (1266) + TX, methamidophos (527) + TX, methanesulfonyl fluoride (name of IUPAC / Chemical Abstracts) (1268) + TX, metidation (529) + TX, methiocarb (530) + TX, methocrotophos (1273) + TX, methomyl (531) + TX, methoprene (532) + TX, methoquin-butyl (1276) + TX, methotrine (alternative name) (533) + TX, methoxychlor (534) + TX, methoxyfenozide (535) + TX, methyl bromide (537) + TX, methyl isocyanate (543) + TX, methyl chloroform (alternative name) [CCN] + TX, methylene chloride [CCN] + TX, metofluthrin [CCN] + TX, metolcarb (550) + TX, methoxadiazone (1288) + TX, mevinfos (556) + TX, mexacarbate (1290) + TX, milbemectin (557) + TX, milbemycin oxime (alternative name) [CCN] + TX, mipafox (1293) + TX, mirex (1294) + TX, monocrotophos (561) + TX, morphothion (1300) + TX, moxidectin (alternative name) [CCN] + TX, naphthalophos (alternate name) [CCN] + TX, naled (567) + TX, naphthalene (name of IUPAC / Chemical Abstracts) (1303) + TX, NC-170 (code under development) (1306) + TX, NC-184 ( compound code) + TX, nicotine (578) + TX, nicotine sulfate (578) + TX, nifluride (1309) + TX, nitenpyram (579) + TX, nitiazine (1311) + TX, nitrilacarb (1313) + TX , nitrilacarb 1: 1 zinc chloride complex (1313) + TX, NNI-0101 (compound code) + TX, NNI-0250 (compound code) + TX, nornicotine (traditional name) (1319) + TX, novaluron (585) + TX, noviflumuron (586) + TX, O-ethyl ethylphosphonothioate of O-2,5-dichloro-4-iodophenyl (IUPAC name) (1057) + TX, 0-4-methyl-2-oxo- 2H-chromen-7-yl phosphorothioate 0.0-diethyl (IUPAC name) (1074) + TX, O-6-methyl-2-propylpyrimidin-4-yl O-O-diethyl dithiopyrofosphate (IUPAC name) ) (1075) + TX, O, O, O ', O' -tetrapropyl dithiopriophosphate (name of IUPAC) (1424) + TX, oleic acid (IUPAC name) (593) + TX, ometoate (594) + TX, oxamyl (602) + TX, oxidemeton-methyl (609) + TX, oxideprofos (1324) ) + TX, oxidisulfoton (1325) + TX, pp '-DDT (219) + TX, para-dichlorobenzene [CCN] + TX, paration (615) + TX, parathion-methyl (616) + TX, penfluron (alternative name) ) [CCN] + TX, pentachlorophenol (623) + TX, pentachlorophenyl laurate (name of IUPAC) (623) + TX, permethrin (626) + TX, petroleum oils (alternative name) (628) + TX, PH 60-38 (code under development) (1328) + TX, fenkapton (1330) + TX, phenothrin (630) + TX, fentoate (631) + TX, phorate (636) + TX, phosalone (637) + TX, phospholan (1338) + TX, fosmet (638) + TX, fosniclor (1339) + TX, phosphamidon (639) + TX, phosphine (IUPAC name) (640) + TX, phoxim (642) + TX, phoxim-methyl (1340) + TX, pyrimethaphos (1344) + TX, pirimicarb (651) + TX, pirimiphos-ethyl (1345) + TX, pirimiphos-methyl (652) + TX, isomers of polychlorodicyclopentadiene (IUPAC name) (1346) + TX, polychloroterpenes ( traditional name) (1347) + TX, potassium arsenite [CCN] + TX, potassium thiosyanate [CCN] + TX, praletrin (655) + TX, precocene I (alternative name) [CCN] + TX, precocene II (name alternative) [CCN] + TX, precocene III (alternative name) [CCN] + TX, primidofos (1349) + TX, profenofos (662) + TX, profluthrin [CCN] + TX, promacil (1354) + TX, promecarb ( 1355) + TX, propafos (1356) + TX, propetamfos (673) + TX, propoxur (678) + TX, protidation (1360) + TX, protiofos (686) + TX, p rotoato (1362) + TX, protrifenbute [CCN] + TX, pymetrozine (688) + TX, pyraclofos (689) + TX, pyrazophos (693) + TX, piresmethrin (1367) + TX, pyrethrin I (696) + TX, pyrethrin II (696) + TX, pyrethrins (696) + TX, pyridaben (699) + TX, pyridalyl (700) + TX, pyridafention (701) + TX, pyrimidifen (706) + TX, pyrimitate (1370) + TX, pyriproxyfen (708) + TX, quassia (alternate name) [CCN] + TX, quinalphos (711) + TX, quinalphos-methyl (1376) + TX, quinotion (1380) + TX, quintiofos (1381) + TX, R- 1492 (code under development) (1382) + TX, rafoxanide (alternate name) [CCN] + TX, resmethrin (719) + TX, rotenone (722) + TX, RU 15525 (code under development) (723) + TX, RU 25475 (code in development) (1386) + TX, riania (alternative name) (1387) + TX, ryanodina (traditional name) (1387) + TX, sabadila (alternative name) (725) + TX, schradan (1389) + TX, sebufos (alternative name) + TX, selamectin (alternative name) [CCN] + TX, SI-0009 (compound code) + TX, silafluofen (728) + TX, SN 72129 (code under development) (1397) + TX, sodium arsenite [CCN] + TX, sodium cyanide (444) + TX, sodium fluoride (IUPAC- / Chemical Abstracts-Name) (1399) + TX, sodium hexafluorosilicate (1400) + TX, sodium pentochlorophenoxide (623) + TX, selenate sodium (IUPAC name) (1401) + TX, sodium thiocyanate [CCN] + TX, sofamide (1402) + TX, spinosad (737) + TX, spiromesifen (739) + TX, sulcofuron (746) + TX, sulcofuron-sodium (746) + TX, sulfluramid (750) + TX, sulfotep (753) + TX, sulfuryl fluoride (756) + TX, sulprofos (1408) + TX, tarred petroleum (alternative name) (758) + TX , tau-fluvalinate (398) + TX, tazimcarb (1412) + TX, TDE (1414) + TX, tebufeno-zide (762) + TX, tebufenpyrad (763) + TX, tebupirimfos (764) + TX, teflubenzuron (768) ) + TX, tefluthrin (769) + TX, temephos (770) + TX, TEPP (1417) + TX, teralethrin (1418) + TX, terbam (name alter native) + TX, terbufos (773) + TX, tetrachloroethane [CCN] + TX, tetrachlorvinphos (777) + TX, tetramethrin (787) + TX, teta-cypermethrin (204) + TX, thiacloprid (791) + TX, thiafenox (alternative name) + TX, thiamethoxam (792) + TX, ticrophos (1428) + TX, thiocarboxim (1431) + TX, thiocyclam (798) + TX, thiocyclam hydrogen oxalate (798) + TX, thiodicarb (799) + TX , thiofanox (800) + TX, thiometon (801) + TX, thionazin (1434) + TX, thiosultap (803) + TX, thiosultap-sodium (803) + TX, thuringiensin (alternative name) [CCN] + TX, tolfenpirad (809) + TX, tralometrine (812) + TX, transfluthrin (813) + TX, transpermethrin (1440) + TX, triamiphos (1441) + TX, triazamate (818) + TX, triazophos (820) + TX, triazuron ( alternative name) + TX, trichlorfon (824) + TX, trichlormetaphos-3 (alternative name) [CCN] + TX, trichloronat (1452) + TX, triphenophos (1455) + TX, triflumuron (835) + TX, trimetacarb (840) ) + TX, tripreno (1459) + TX, vamidotion (847) + TX, vaniliprol [CCN] + TX, veratridine (alternative name) ) (725) + TX, veratrine (alternative name) (725) + TX, XMC (853) + TX, xylilcarb (854) + TX, YI-5302 (compound code) + TX, zeta-cypermethrin (205) + TX, zetamethrin (alternate name) + TX, zinc phosphide (640) + TX, zolaprofos (1469) and ZXI 8901 (code under development) (858) + TX, a molluscicide selected from the group of substances consisting of bis oxide (tributyltin) (name of UIPAC) (913 + TX, bis (tributyltin) oxide (IUPAC-Name) (913) + TX, bromoacetamide [CCN] + TX, calcium arsenate [CCN] + TX, cloetocarb (999) + TX, copper acetoarsenite [CCN] + TX, copper sulfate (172) + TX, fentin (347) + TX, ferric phosphate (IUPAC-Name) (352) + TX, metaldehyde (518) + TX, methiocarb ( 530) + TX, niclosamide (576) + TX, niclosamide-olamine (576) + TX, pentachlorophenol (623) + TX, sodium pentachlorophenoxide (623) + TX, tazimcarb (1412) + TX, thiodicarb (799) + TX , tributyltin oxide (913) + TX, trifenmorph (1454) + TX, trimetacarb (840) + TX, a triphenyltin cetate (IUPAC-Name) (347) and triphenyltin hydroxide (IUPAC-Name) (347) + TX, a nematicide selected from the group consisting of AKD-3088 (compound code) + TX, 1 + TX , 2-dibromo-3-chloropropane (IUPAC / Chemical Abstracts name) (1045) + TX, 1 + TX, 2-dichloropropane (IUPAC name / Chemical Abstracts) (1062) + TX, 1 + TX, 2-dichloropropane with 1 + TX, 3-dichloropropene (IUPAC name) (1063) + TX, 1 + TX, 3-dichloropropene (233) + TX, 3+ TX, 4-dichlorotetrahydrothiophene + TX, 1-dioxide (IUPAC name / Chemical Abstracts) (1065) + TX, 3- (4-chlorophenyl) -5-methylrodanine (IUPAC name) (980) + TX, 5-methyl-6-thioxo-1, 3, 5-thiadiazin-3-acid ilacetic (IUPAC name) (1286) + TX, 6-isopentenylaminopurine (alternative name) (210) + TX, abamectin (1) + TX, acetoprol [CCN] + TX, alanicarb (15) + TX, aldicarb (16) + TX, aldoxicarb (863) + TX, AZ 60541 (compound code) + TX, benclotiaz [CCN] + TX, benomyl (62) + TX, buti lpiridaben (alternative name) + TX, cadusafos (109) + TX, carbofuran (118) + TX, carbon disulfide (945) + TX, carbosulfan (119) + TX, chloropicrin (141) + TX, chlorpyrifos (145) + TX, cloetocarb (999) + TX, cytokines (alternative name) (210) + TX, dazomet (216) + TX, DBCP (1045) + TX, DCIP (218) + TX, diamidaphos (1044) + TX, diclofention (1051) + TX, dicliphos ( alternative name) + TX, dimethoate (262) + TX, doramectin (alternative name) [CCN] + TX, emamectin (291) + TX, emamectin benzoate (291) + TX, eprinomectin (alternative name) [CCN] + TX , ethoprophos (312) + TX, ethylene cybromide (316) + TX, fen-amyphos (326) + TX, fenpyrad (alternative name) + TX, fensulfothion (1158) + TX, fosthiazate (408) + TX, fostietan ( 1196) + TX, furfural (alternate name) [CCN] + TX, GY-81 (code under development) (423) + TX, heterophos [CCN] + TX, isamidophos (1230) + TX, isazophos (1231) + TX , ivermectin (alternate name) [CCN] + TX, kinetin (alternative name) (210) + TX, mecarphone (1258) + TX, metam (519) + TX, metam -potassium (alternative name) (519) + TX, metam-sodium (519) + TX, methyl bromide (537) + TX, methyl isothiocyanate (543) + TX, milbemycin oxime (alternative name) [CCN] + TX, moxidectin (alternative name) [CCN] + TX, composition Myrotheci um verrucaria (alternative name) (565) + TX, NC-184 (compound code) + TX, oxamyl (602) + TX, phorate (636) + TX, phosphamidon (639) + TX, phosphocarb [CCN] + TX, sebufos (alternative name) + TX, selamectin (alternative name) [CCN] + TX, spinosad (737) + TX, terbam (alternative name) + TX, terbufos (773) + TX, tetrachlorothiophene (IUPAC- / Chemical Abstracts-Name) (1422) + TX, thiafenox (alternative name) + TX, tionazin (1434) + TX, triazophos (820) + TX, triazuron (alternative name) + TX, xylene [CCN] + TX, YI-5302 (compound code) and zeatin (alternative name) (210) + TX, a nitrification inhibitor selected from the group of substances consisting of potassium ethylxanthate [CCN] and nitrapyrin (580) + TX, a plant activator selected from the group of substances consisting of acibenzolar (6) + TX, acibenzolar-S-methyl (6) + TX, probenazole (658) and extract of Reynoutria sa cha l inensis (alternative name) (720) + TX, a rodenticide selected from the group of substances consisting of 2-isovalerilindan-l + TX, 3-dione (name of IUPAC) (1246); 4- (quinoxalin-2-ylamino) benzenesulfonamide (IUPAC name) (748) + TX alpha-chlorohydrin [CCN] + TX, aluminum phosphide (640) + TX, antu (880) + TX, arsenious oxide (882) + TX, barium carbonate (891) + TX, bistiosemi (912) + TX, brodifacoum (89) + TX, bromadiolone (91) + TX, bromrometal (92) + TX, calcium cyanide (444) + TX, chloralose (127) + TX, chlorophacinone (140) + TX, cholecalciferol (alternative name) (850) + TX, cumaclor (1004) + TX, cumafuril (1005) + TX, coumatetralyl (175) + TX, crimidine (1009) + TX, difenacum (246) + TX, difetialone (249) + TX, diphacinone (273) + TX, ergocalciferol (301) + TX, flocumafen (357) + TX, fluoracetamide (379) + TX, flupropadine (1183) + TX, flupropadine hydrochloride (1183) + TX, range-HCH (430) + TX, HCH (430) + TX, hydrogen cyanide (444) + TX, lindane (430) + TX, magnesium phosphide (IUPAC-Name) (640) + TX, methyl bromide ( 537) + TX, norbormide (1318) + TX, fosacetim (1336) + TX, phosphine (IUPAC-Name) (640) + TX, phosphorus [CCN] + TX, pindone (1341) + TX, potassium arsenite [CCN] ] + TX, pirinuron (1371) + TX, sciliroside (1390) + TX, sodium arsenite [CCN] + TX, sodium cyanide (444) + TX, sodium fluoracetate (735) + TX, strychnine (745) + TX, thallium sulfate [CCN] + TX, warfarin (851) and zinc phosphide (640) + TX, a synergist selected from the group consisting of 2- (2-butoxyethoxy) ethyl piperolinate (IUPAC name) (934) + TX, 5- (1, 3-benzodioxol-S-il) -3-hexylcyclohex-2-enone (IUPAC-Name) (903) + TX, farnesol with nerolidol (name alter native) (324) + TX, MB-599 (code under development) (498) + TX, MGK 264 (code under development) (296) + TX, piperonyl butoxide (649) + TX, piprotal (1343) + TX , propyl isomer (1358) + TX, S421 (code under development) (724) + TX, sesamex (1393) + TX, sesasmolin (1394) and sulfoxide (1406) + TX, an animal repellent selected from the group of substances consisting of anthraquinone (32) + TX, chloralose (127) + TX, copper naphthenate [CCN] + TX, copper oxychloride (171) + TX, diazinon (227) + TX, dicyclopentadiene (chemical name) (1069) + TX, guazatine (422) + TX, guazatin acetates (422) + TX, methiocarb (530) + TX, pyridin-4-amine (IUPAC name) (23) + TX, thiram (804) + TX, trimetacarb (840) + TX, zinc naphthenate [CCN] and ziram (856) + TX, a virucide selected from the group of substances consisting of imanin (alternative name) [CCN] and ribavirin (alternative name) [CCN] + TX, and a wound protector selected from the group of substances consisting of mercury oxide (512) + TX, octylinone (590) and thiophanate-methyl (802) + TX, the compound of formula A-1 the formula A-2 the formula A-3 the formula A-4 the formula A-5 the formula A- 6 the formula A-7 the formula A-i the formula A-9 the formula A-10 the formula A-12 the formula A-13 the formula A-14 the formula A- 15 the formula A-16 the formula A-17 the formula A-lí Formula A-19 Formula A-20 Formula A-21 Formula A-22 Formula A-23 Formula A-24 the formula A-25 the formula A-26 and Azaconazole (60207-31-0] + TX, Bitertanol [70585-36-3] + TX, Bromuconazole [116255-48-2] + TX, Ciproconazole [94361-06-5] + TX, Difenoconazole [119446-68] -3] + TX, Diniconazole [83657-24-3] + TX, Epoxiconazole [106325-08-0] + TX, Fenbuconazole [114369-43-6] + TX, Fluquinconazole [136426-54-5] + TX, Flusilazole [85509-19-9] + TX, Flutriafol [76674-21-0] + TX, Hexaconazole [79983-71-4] + TX, Imazalil [35554-44-0] + TX, Imibenconazole [86598-92- 7] + TX, Ipconazole [125225-28-7] + TX, Metconazole [125116-23-6] + TX, Miclobutanil [88671-89-0] + TX, Pefurazoate [101903-30-4] + TX, Penconazol [66246-88-6] + TX, Protioconazole [178928-70-6] + TX, Pirifenox [88283-41-4] + TX, Prochloraz [67747-09-5] + TX, Propiconazole [60207-90-1] ] + TX, Simeconazole [149508-90-7] + TX, Tebuconazole [107534-96-3] + TX, Tetraconazole [112281-77-3] + TX, Triadimefon [43121-43-3] + TX, Triadimenol [ 55219-65-3] + TX, Triflumizol [99387-89-0] + TX, Triticonazole [131983-72-7] + TX, Ancymidol [12771-68-5] + TX, Fenarimol [60168-88-9]+ TX, Nuarimol [63284-71-9] + TX, Bupirimate [41483-43-6] + TX, Dimetirimol [5221-53-4] + TX, Etirimol [23947-60-6] + TX, Dodemorf [1593 -77-7] + TX, Fenpropidin [67306-00-7] + TX, Fenpropimorf [67564-91-4] + TX, Spiroxamine [118134-30-8] + TX, Tridemorf [81412-43-3] + TX, Ciprodinil [121552-61-2] + TX, Mepanipirim [110235-47-7] + TX, Prrimetanil [53112-28-0] + TX, Fenpiclonil [74738-17-3] + TX, Fludioxonil [131341-86-1] + TX, Benalaxil [71626-11-4] + TX, Furalaxil [57646-30-7] + TX, Metalaxyl [57837-19-1] + TX, R-Metalaxyl [70630-17-0] + TX, Ofurace [58810-48-3] + TX, Oxadixil [77732-09] -3] + TX, Benomil [17804-35-2] + TX, Carbendazim [10605-21-7] + TX, Debacarb [62732-91-6] + TX, Fuberidazole [3878-19-1] + TX, Thiabendazole [148-79-8] + TX, Clozolinate [84332-86-5] + TX, Diclozoline [24201-58-9] + TX, Iprodione [36734-19-7] + TX, Miclozolin [54864-61-] 8] + TX, Procymidone [32809-16-8] + TX, Vinclozolin [50471-44-8] + TX, Boscalid [188425-85-6] + TX, Carboxin [5234-68-4] + TX, Fenfuram [24691-80-3] + TX, Flutolanil [66332-96-5] + TX, Mepronil [55814-41-0] + TX, Oxycarboxine [5259-88-1] + TX, Pentiopirad [183675-82-3] ] + TX, Tifluzamide [130000-40-7] + TX, Guazatina [108173-90-6] + TX, Dodina [2439-10-3] [112-65-2] (Free base) + TX, Iminoctadine [ 13516-27-3] + TX, Azoxystrobin [131860-33-8] + TX, Dimoxiestrobinan [149961-52-4] + TX, Enestroburin. { Proc. BCPC + TX, Int. Congr. + TX, Glasgow + TX, 2003 + TX, 1 + TX, 93.}. + TX, Fluoxaestrobin [361377-29-9] + TX, Kresoxim-methyl [143390-89-0] + TX, Metominoestrobin [133408-50-1] + TX, Trifloxystrobin [141517-21-7] + TX, Orisaestrobina [248593-16-0] + TX, Picoxiestrobin [117428-22-5] + TX, Piraclostrobin [175013-18-0] + TX, Ferbam [14484-64-1] + TX, Mancozeb [8018-01-7] ] + TX, Maneb [12427-38-2] + TX, Metiram [9006-42-2] + TX, Propineb [12071-83-9] + TX, Tiram [137-26-8] + TX, Zineb [ 12122-67-7] + TX, Ziram [137-30-4] + TX, Captafol [2425-06-1] + TX, Captan [133-06-2] + TX, Diclofluanid [1085-98-9] + TX, Fluorimide [41205-21-4] + TX, Folpet [133-07-3] + TX, Tolilfluanid [731-27-1] + TX, Bordeaux Mixture [8011-63-0] + TX, hydroxide copper [20427-59-2] + TX, copper oxychloride [1332-40-7] + TX, copper sulfate [7758-98-7] + TX, copper oxide [1317-39-1] + TX, Mancopper [53988-93-5] + TX, Oxina-copper [10380-28-6] + TX, Dinocap [131-72-6] + TX, Nitrotal-isopropyl [10552-74-6] + TX, Edifenfos [ 17109-49-8] + TX, Iprobenfos [26087-47-8] + TX, Iso protiolane [50512-35-1] + TX, Fosdifen [36519-00-3] + TX, Pirazophos [13457-18-6] + TX, Tolclofos-methyl [57018-04-9] + TX, Acibenzolar-S- methylol [135158-54-2] + TX, Anilazine [101-05-3] + TX, Bentiavalicarb [413615-35-7] + TX, Blasticidin-S [2079-00-7] + TX, Cinometionat [2439- 01-2] + TX, Cloroneb [2675-77-6] + TX, Chlorothalonil [1891-45-6] + TX, Ciflufenamid [180409-60-3] + TX, Cimoxanil [51966-95-1] + TX , Diclone [11 1-80-6] + TX, Diclocimet [139920-32-4] + TX, Diclomezine [62865-36-5] + TX, Dicloran [99-30-9] + TX, Dietofencarb [81130- 20-9] + TX, Dimetomorf [110488-10-5] + TX, SYP-LI90 (Flumorf) [211861-41-9] + TX, Ditianon [3341-22-6] + TX, Etaboxam [1 62650- 11-3] + TX, Etridiazole [2593-15-9] + TX, Famoxadone [131801-51-3] + TX, Fenamidone [1 61326-34-1] + TX, Fenoxanil [115852-48-1] + TX, Fentin [668-34-8] + TX, Ferimzone [89269-64-1] + TX, Fluazinam [79622-59-6] + TX, Fluopicolide [239110-15-7] + TX, Flusulfamide [106917- 52-6] + TX, Fenhexamid [126833-17-8] + TX, Fose Til-aluminum [39148-24-8] + TX, Himexazole [10004-44-1] + TX, Iprovalicarb [140923-17-7] + TX, IKF-916 (Ciazofamid) [12011 6-88-3] + TX, Kasugamycin [6980-18-3] + TX, Metasulfocarb [66952-49-6] + TX, Metrafenone [220899-03-6] + TX, Pencicuron [66063-05-6] + TX, Ftalida [27355- 22-2] + TX, Polyoxins [11113-80-7] + TX, Probenazole [27605-76-1] + TX, Propamocarb [25606-41-1] + TX, Proquinazid [189278-12-4] + TX , Piroquilon [57369-32-1] + TX, Quinoxifen [124495-18-7] + TX, Quintozeno [82-68-8] + TX, Schwefel [7704-34-9] + TX, Tiadinil [223580-51] -6] + TX, Triazoxide [72459-58-6] + TX, Tricyclazole [41814-78-2] + TX, Triforin [26644-46-2] + TX, Validamycin [37248-47-8] + TX, Zoxamide (RH7281) [156052-68-5] + TX, Mandipropamid [374726-62-2] + TX, the compound of formula F-1 wherein Ra5 is trifluoromethyl or difluoromethyl; 02004/058723) + TX,; the compound of formula F-2 wherein Ra6 is trifluoromethyl or difluoromethyl (O2004 / 058723) + TX,; the racemic compound of formula F-3 (without) wherein Ra7 is trifluoromethyl or difluoromethyl (WO2004 / 035589) + TX, the racemic mixture of formula F-4 (anti) wherein Ra7 is trifluoromethyl or difluormetlo WO2004 / 035589) + TX, the compound of formula F-5 CH, which is an epimeric mixture of racemic compounds of formulas F-3 (without) and F-4 (anti), where the ratio between racemic compounds of formula F-3 (without) to racemic compounds of formula F-4 ( anti) is from 1000: 1 to 1: 1000 and where Ra7 is trifluoromethyl or difluoromethyl (WO2004 / 035589) + TX, the compound of formula F-6 wherein Ra8 is trifluoromethyl or difluoromethyl (O2004 / 035589) + TX, the racemic compound of formula F-7 (trans) wherein Rag is trifluoromethyl or difluoromethyl (WO03 / 074491) + TX, the racemic compound of formula F- (cis) wherein Ra9 is trifluoromethyl or difluoromethyl; O03 / 074491) + TX, the compound of formula F-9 which is a mixture of the racemic compounds of the formulas F-7 (trans) and F-8 (cis), where the ratio of racemic compounds of formula F-7 (trans) to racemic compounds of formula F-8 (cis ) is 2: 1 to 100: 1; and wherein Ra9 is trifluoromethyl or difluoromethyl (WO03 / 074491) + TX, the compound of formula F-10 wherein Rio is trifluoromethyl or difluoromethyl; 02004/058723) + TX, the racemic compound of formula F-ll (trans) wherein Rn is trifluoromethyl or difluoromethyl (document O03 / 074491) + TX, the racemic compound of formula F-12 (cis) wherein Ru is trifluoromethyl or difluoromethyl [document O03 / 074491) + TX, the compound of formula F-13 which is a racemic mixture of formula F-ll (trans) and F-12 (cis), and where Rn is trifluoromethyl or difluoromethyl (WO 03/074491) + TX, and the compound of formula F-14 (WO2004 / 058723) + TX, and the compound of formula F-15 + TX The active ingredient mixture of the compounds of formula I selected from Tables A and B with the active ingredients described above comprises a compound selected from Tables A and B and an active ingredient such as that described above preferably in a mixture ratio of from about 100: 1 to 1: 6000, especially from 50: 1 to 1:50, more especially in a ratio of from 20: 1 to 1:20, even more especially from 10: 1 to 1:10, most especially from 5: 1 and 1: 5, with special preference being given to a ratio of from 2: 1 to 1: 2, and also being a preferred ratio of 4: 1 to 2: 1 mainly in a ratio of 1: 1, or 5: 1, or 5: 2, or 5: 3, or 5: 4, or 4: 1, or 4: 2, or 4: 3, or 3: 1, or 3: 2, or 2: 1, or 1: 5, or 2: 5, or 3: 5, or 4: 5, or 1: 4, or 2: 4, or 3: 4, or 1: 3, or 2: 3, or 1: 2, or 1: 600, or 1: 300, or 1: 150, or 1:35, or 2:35, or 4:35, or 1:75, or 2:75, or 4:75, or 1: 6000, or 1: 3000, or 1: 1500, or 1: 350, or 2: 350, or 4: 350, or 1: 750, or 2: 750, or 4: 750. Said mixing ratios include, on the one hand, the weight ratios and also, on the other hand, the molar ratios. Mixtures comprising a compound of formula I selected from Tables A and B, and one or more active ingredients described above may be applied, for example, to a single form (rapid mixture) in a combined spray mixture comprised of separate formulations of the components of the sole active ingredient, such as a "tank mix", and in a combined use of the unique active ingredients when applied consecutively ie one after the other for a reasonably short period such as a few hours or days. The order of application of the compounds of formula I selected from Tables A and B, and the active ingredients described above is not essential for carrying out the present invention. References in brackets following the active ingredients, for example, [3878-19-1] refers to the Chemical Abstracts Registry registration number. The compounds of the formulas A-1 to A-26 are described in WO 03/015518 or in WO 04/067528. The mixing pairs described previously are known. When the active ingredients are included in "The Pesticide Manual" [The Pesticide Manual - A World Compendium; Thirteenth Edition; Editor: C. D. S. Tomlin; The British Crop Protection Council], are described herein under the entry number given in parentheses above for the particular compound; for example, the compound "abamectin" is described under the entry number (1). When "[CCN]" is added above to the particular compound, the compound in question is included in "Compendium of Pesticide Common Ñames", which is accessible on the Internet [A. Wood; Compendium of Pesticide Common Ñames, Copyright © 1995-2004]; for example, the compound "acetoprol" is described under the internet address http: // www. alanwood.net/pesticides/acetoprole html Most of the active ingredients described above are referred to below by the so-called "common name", the "relevant ISO common name" or another "common name" used in individual cases. If the designation is not a "common name", the nature of the designation used in its place is given in parentheses for the particular compound; in this case, the name of IUPAC, the name of IUPAC / Chemical Abstracts, a "chemical name", a "traditional name", a "compound name", or a "development code", or, if not none of these designations or a "common name" is used, an "alternative name" is used. "CAS Reg. No" means the registration number of Chemical Abstracts Registry Number.

Biological Examples (% = percent by weight, unless otherwise specified).

Example Bl: Activity against Cydia pomonella: Cydia standard cubes (1.5 cm wide) were drilled with a toothpick and immersed in liquid paraffin (ca. 80 ° C). Once the paraffin coating has hardened, an aqueous emulsion containing 400 ppm of active ingredient is applied using a De Vilbis sprayer (25 ml, 1 bar). Once the sprayed coating is dry, the cubes are placed in plastic containers that are then populated with two recently placed Cydia pomonella (ler stadium). Then the containers are closed with a plastic lid. After 14 days of incubation at 26 ° C and under a relative humidity of 40-60%, the survival rate of the caterpillars is determined, as well as their growth regulation. In this test, the compounds listed in Table C above, show good activity. In particular, compounds A.1.1, A.1.13, A.1.7 and A.1.4 have an activity of more than 80%.

Example B2: Activity against Diabrotica balteata Corn plants were sprayed with a mixture of an aqueous spray emulsion comprising 400 ppm of active ingredient and, when the spray coating has dried, it is populated with ten larvae (second stage) of Diabrotica. balteata and are introduced inside a plastic container. Six days later, the percentage reduction in the population (% activity) is determined by comparing the number of dead larvae between treated and untreated plants. In this test, the compounds listed in Table C above, show good activity. In particular, compounds A.1.13, A.1.1, A.1.4, B. 1.28, A.1.122 and A.1.7 have an activity of 80%.

Example B3: Activity against Heliothis virescens (foliar application) Young soybean plants were sprayed with an aqueous emulsion spray mixture comprising 400 ppm of active ingredient and, once dried, the spray coating is populated with 10 caterpillars (first stage). ) of Heliothis virescens and are placed inside a plastic container. Six days later the percent reduction in the polation is determined and the feed deterioration (% activity) is determined by comparing the number of dead caterpillars and the feeding deterioration between the treated and untreated plants. In this test, the compounds listed in Table C above show good activity. In particular, compounds A.1.13, A.1.4, A.1.1 and A.1.7 have an activity of more than 80%.

Example B4: Activity against Heliothis virescens (application to eggs) Heliothis eggs, which had been deposited on cotton, were sprayed with an aqueous spray emulsion mixture comprising 400 ppm of active ingredient. After 8 days, the percentage of egg laying and the survival rate of the caterpillars (% activity) were evaluated in comparison with the untreated control groups. In this test, the compounds listed in Table C above show good activity. Compounds A.1.13, A.1.1, A.1.4, B. 1.28, A.1.122, A.1.57, A.1.131 and A.1.7 have an activity of more than 80%.

Example B5: Activity against Myzus persicae (foliar application) Pea plants were infected with Myzus persicae, and were subsequently sprayed with a spray mixture comprising 400 ppm of active ingredient and then incubated at 20 °. 3 and 6 days later, the percentage reduction of the population (% activity) was determined, comparing the amount of dead acids between the treated and untreated plants. In this test, the compounds listed in Table C above show good activity. In particular, compounds A.1.13, A.1.4, A.1.122 and A.1.7 have an activity of more than 80%.

Example B6: Activity against Myzus persicae (systemic application) Pea plants were infected with Myzus persicae, and their roots were subsequently placed in a spray mixture comprising 400 ppm of active ingredient. The plants were then incubated at 20 °. 3 and 6 days later, the percentage reduction in the population (% activity) was determined by comparing the number of dead aphids between treated and untreated plants. In this test, the compounds listed in Table C, above, show good activity. In particular, compounds A.1.4, A.1.122 and A.1.7 have an activity of more than 80%.

Example B: Activity against Plutella xylostella Young cabbage plants were sprayed with a mixture of an aqueous sprayed emulsion comprising 400 ppm of active ingredient and, after drying the spray coating, populated with 10 caterpillars (3rd stage) of Plutella xylostella and were introduced inside a plastic container. Three days later, the percentage reduction in the population and the deterioration due to feeding (% activity) was determined by comparing the number of dead caterpillars and the deterioration by feeding between the treated and untreated plants. In this test, the compounds listed in Table C above show good activity. In particular the compounds A.1.13, A.1.1, A.1.4, B. 1.28, A.1.122, A.1.57, A.1.131, A.1.134 and A.1.7 have an activity of more than 80% Example B8: Activity against Spodoptera littoralis Young soybean plants were sprayed with a mixture of an aqueous sprayed emulsion comprising 400 ppm of active ingredient and, after drying the spray coating, populated with 10 caterpillars (ler stadium) of Spodoptera littoralis and were introduced into a plastic container Three days more tarae, u-eu? Up? s plastic container. Three days later, the percentage reduction in the population and the deterioration due to feeding (% activity) was determined by comparing the number of dead caterpillars and the deterioration by feeding between the treated and untreated plants. In this test, the compounds listed in Table C above show good activity. In particular, compounds A.1.13, A.1.1, A.1.4, B. 1.28, A.1.122, A.1.57, A.1.131 and A.1.7 have an activity of more than 80%.

Example B9: Systemic insecticide Assay for Spodoptera l i t toralis (cotton leaf worm): Four-day-old corn plants. { Zea mais, Stoneville variety) were individually placed in jars containing 24ml of water within which the chemical was diluted to 12.5 ppm. The plants were allowed to grow for six days. Subsequently the leaves were cut and placed in a Petri dish (with a diameter of 5 cm), they were inoculated with twelve to fifteen S larvae. li t toralis from first stage and incubated for four days in a first growth chamber (25 ° C, 50% room humidity, 18: 6 L: D photo period). The number of live insects was counted and the mortality percentage was calculated. The tests were carried out with a replica. In this test, the compounds listed in Table C show good activity.

In particular, compounds A.1.13, A.1.1, A.1.4, A.1.7, A.1.13, A.1.122, A.1.131 and B1.28 have an activity of more than 80%.

Example BIO Activity against Frankliniella occidentalis: Leaf discs of beans on agar in petri dishes or bean plants in a spray chamber were treated with diluted test solutions. After removing leaf discs, they were cut and placed in plastic boxes on the surface of an agar layer and infested with a mixed population. Six days (leaf discs) or fourteen days (plants) after the infestation, the samples were checked to determine the reduction of the treated population and compared with the untreated population. In this test, the compounds listed in Table C showed good activity. In particular, compounds A.1.1, A.1.4, A.1.13, A.1.122 and A.1.7 have an activity of more than 80%. It is noted that in relation to this date, the best method known by the applicant to carry out the aforementioned invention, is that which is clear from the present description of the invention.

Claims (13)

1. CLAIMS Having described the invention as above, the content of the following claims is claimed as property. 1. Compound of formula I characterized in that each of E and z, which may be the same or different, represents oxygen or sulfur; A is C? -C6 alkylene, C2-Cd alkenylene, C2-C6 alkynylene, or a monocyclic or bicyclic bivalent ring system of three to ten elements which may be partially saturated or fully saturated and which may contain 1 to 4 heteroatoms selected from group formed by nitrogen, oxygen and sulfur, where it is not possible for each ring system to contain more than 2 oxygen atoms and more than 2 sulfur atoms; and where it is possible for the system itself of rings of three to ten elements and also the alkylene groups C? -C6, 14! C2-C6 alkenylene and C2-C6 alkynylene are mono-, di- or trisubstituted with halogen, cyano, nitro, hydroxy, Ci-Cd alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C3-C6 cycloalkyl, C5-C7 cycloalkenyl , C5-C8 cycloalkynyl, Ci-C3 haloalkyl, C2-C6 haloalkenyl, C2-C6 haloalkynyl, C3- [alpha] haloalkyl, C5-C7 halocycloalkenyl, C5-Cs halocycloalkynyl, C1-C4 alkoxy, C1-C4 haloalkoxy, C5-alkylthio C4, C 1 -C 4 haloalkylthio, C 1 -C 4 alkylsulfinyl, C 1 -C 4 alkylsulfonyl, C 1 -C 4 alkylamino, C 2 -C 4 dialkylamino, C 3 -C 6 cycloalkylamino, C 1 -C 4 alkylcycloalkylamino, C 2 -C 4 alkylcarbonyl, C2-Cd alkoxycarbonyl, C2-C6 alkylaminocarbonyl, C3-? dialkylaminocarbonyl, C2-C6 alkoxycarbonyloxy, C2-C6 alkylaminocarbonyloxy, C3-C6 dialkylaminocarbonyloxy or C3-C6 trialkylsilyl, or by a fused monocyclic or bicyclic ring system of three to ten elements which may be aromatic, partially saturated or fully saturated and may contain 1 to 4 selected heteroatoms of the group consisting of nitrogen, oxygen and sulfur, where it is not possible for each ring system to contain more than 2 oxygen atoms and more than 2 sulfur atoms, and where it is possible for the ring system itself to have three to ten elements is mono-, di- or trisubstituted with halogen, cyano, nitro, hydroxy, C?-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C3-C6 cycloalkyl, C5-C7 cycloalkenyl, C5-C8 cycloalkynyl, haloalkyl, Cß, C2-C6 haloalkenyl, C2-C6 haloalkynyl, C3-C6 haloalkyl, C5-C7 haloalkyl, C5-C8 halocycloalkynyl, C? -C4 alkoxy, C? -C haloalkoxy, C? -C4 alkylthio, haloalkylthio C? C4 , C 1 -C 4 alkylsulfinyl, C 1 -C alkylsulfonyl, C 1 -C 4 alkylamino, C 2 -C 4 dialkylamino, C 3 -C 6 cycloalkylamino, C 1 -C 6 -cycloalkylamino C 3 -C 6 alkyl, C 2 -C 4 alkylcarbonyl, C 2 -C 6 alkoxycarbonyl, C2-C6 alkylaminocarbonyl, C3-C6 dialkylaminocarbonyl, C2-C6 alkoxycarbonyloxy, C2-C6 alkylaminocarbonyloxy, C3-C6 dialkylaminocarbonyloxy, trialkylsilyl or C3-C6 or phenyl, where it is possible that the phenyl group is itself substituted with hydroxy, Ci-Cß alkyl, Ci-C halo haloalkyl, C?-C6 alkylthio, Ci-Ce haloalkylthio, C3-Cd alkenylthio, haloalkenylthio C3 -C6, C3-C3 alkynylthio, C1-C3alkoxy-C1-C3alkylthio, C2-C4alkylcarbonyl-Ccy3alkylthio, C2-C4alkoxycarbaryl C1-C3alkyloxy, cyano-alkylthio Cj.-C3, alkylsulfinyl C? -C6, haloalkylsulfinyl Ci-Cs, alkylsulfonyl C? -C6, haloalkylsulfonyl Ci-Cß, aminosulfonyl, alkylaminosulfonyl C? -C2, N, N-di (C? -C2 alkyl) aminosulfonyl, di (C? -C) alkyl amino , halogen, cyano or nitro; and wherein the substituents on the nitrogen atoms in the ring systems are other than halogen; X is oxygen, NH or C alquilo-C-N alkyl; And it is a monocyclic or bicyclic ring system fused of three to ten elements that can be partially saturated or totally saturated and that can contain 1 to 4 heteroatoms selected from the group formed by nitrogen, oxygen and sulfur, where it is not possible for each system of rings contain more than 2 oxygen atoms and more than 2 sulfur atoms; and where it is possible for the ring system itself of three to ten elements to be mono-, di- or trisubstituted with halogen, cyano, nitro, hydroxy, Ci-Ce alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C3-C6 cycloalkyl, C5-C7 cycloalkenyl, C5-C8 cycloalkynyl, C6-C6 haloalkyl, C2-C6 haloalkenyl, C2-C6 haloalkynyl, C3-C6 haloalkyloxy, C5-C7 halocycloalkenyl, C5-C8 halocycloalkynyl, Ci-C4 alkoxy, C? -C4 haloalkoxy, C? -C alkylthio, haloalkylthio C? -C, alkylsulfinyl C ? -C4, C? -C4 alkylsulfonyl, C? -C4 alkylamino, C2-C4 dialkylamino, C3-C6 cycloalkylamino, C? -C6 alkyl-C3-C6 cycloalkylamino, C2-C4 alkylcarbonyl, C2-C6 alkoxycarbonyl, C2-alkylaminocarbonyl C6, C3-C6 dialkylaminocarbonyl, C2-C6 alkoxycarbonyloxy, C2-C6 alkylaminocarbonyloxy, C3-C6 dialkylaminocarbonyloxy or C3-C6 trialkylsilyl, or with a fused monocyclic or bicyclic ring system of three to ten elements that can be aromatic, partially saturated or fully saturated and which may contain 1 to 4 heteroatoms selected from the group consisting of nitrogen, oxygen and sulfur, where it is not possible for each ring system to contain more than 2 oxygen atoms and more than 2 sulfur atoms, and where it is possible for the ring system itself of three to ten elements to be mono-, di- or trisubstituted with halogen, cyano, nitro, hydroxy, Ci-Cg alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C3-C6 cycloalkyl, C5-C7 cycloalkenyl, C5-C8 cycloalkynyl, Ci-Ce haloalkyl, C2-C6 haloalkenyl, C2-C6 haloalkynyl, C3-C6 haloalkyloxy, C5-C7 haloalkyloxy, C5-C8 haloalkynyl, C4-C4 alkoxy, C4-C4 haloalkoxy, C?-C4 alkylthio, haloalkylthio C?-C, alkylsulfinyl C?-C, C 1 -C 4 alkylsulfonyl, C 1 -C 4 alkylamino, C 2 -C 4 dialkylamino, C 3 -C 6 cycloalkylamino, C 1 -C 6 -cycloalkylamino C 3 -C 6 alkyl, C 2 -C 4 alkylcarbonyl, C 2 -C 6 alkoxycarbonyl, C 2 -C 6 alkylaminocarbonyl, C 3 dialkylaminocarbonyl -C6, C2-C6 alkoxycarbonyloxy, C2-C6 alkylaminocarbonyloxy, C3-C6 dialkylaminocarbonyloxy, C3-C6 trialkylsilyl or phenyl, where it is possible that the The phenyl group is itself substituted by hydroxy, C? -C6 alkyl, C? -C6 haloalkyl, C? -C6 alkylthio, C? -C6 haloalkylthio, C3-C6 alkenylthio, C3-C6 haloalkenylthio, C3-C6 alkynylthio, alkoxy C1-C3-C 1 -C 3 alkylthio, C 2 -C 4 alkylcarbonyl-C 1 -C 3 alkylthio, C 2 -C 4 alkoxycarbonyl-C 1 -C 3 alkylthio, C 1 -C 3 cyano-alkylthio, C 1 -C 6 alkylsulfinyl, C 1 -C 6 haloalkylsulfinyl, C 1 -C 6 alkylsulfonyl; - β, haloalkylsulfonyl Ci-Cg, aminosulfonyl, alkylaminosulfonyl C?-C2, N, N-di (C?-C2 alkyl) aminosulfonyl, di (C?-C4 alkyl) amino, halogen, cyano or nitro; and wherein the substituents on the nitrogen atoms in the ring systems are other than halogen; p is O or l; q is O or 1; B is a system of rings of three to four elements that can be totally or partially saturated and that can contain 1 to 4 heteroatoms selected from the group formed by nitrogen, oxygen and sulfur, where it is possible that the system itself of rings of 3 to 4 elements are mono-, di- or trisubstituted with halogen, cyano, nitro, hydroxy, C? -C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C3-C3 cycloalkyl, C5-C7 cycloalkenyl, C5-C8 cycloalkynyl, haloalkyl C? C6 alkyl, C2-C6 haloalkenyl, C2-C6 haloalkynyl, C3-C6 halocycloalkyl, halocycloalkenyl C5-C7, C5-C8 halocicloalquinilo alkoxy C? ~ C4 haloalkoxy C? ~ C4, alkylthio C? -C4 haloalkylthio C ? -C4, C? -C4 alkylsulfinyl, C? -C4 alkylsulfonyl, C? -C alkylamino, C2-C4 dialkylamino, C3-C6 cycloalkylamino, Ci-Cd-C3-C6 cycloalkylamino alkyl, C2-C4 alkylcarbonyl, C2-alkoxycarbonyl C6, C2-C6 alkylaminocarbonyl, C3-C6 dialkylaminocarbonyl, C2-C6 alkoxycarbonyloxy, C2-C6 alkylaminocarbonyloxy, dialkylaminocarbonyloxy C3-C6 or C3-C6 trialkylsilyl, or with a fused monocyclic or bicyclic ring system of three to ten elements which may be aromatic, partially saturated or fully saturated and may contain 1 to 4 heteroatoms selected from the group consisting of nitrogen, oxygen and sulfur, where it is not possible for each ring system to contain more than 2 oxygen atoms and more than 2 sulfur atoms, and where it is possible that the ring system itself of three to ten elements is mono-, di- or trisubstituted with halogen, cyano, nitro, hydroxy, Ci-Cß alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C3-C6 cycloalkyl, C5-C cycloalkenyl, C5-C8 cycloalkynyl, C?-C6 haloalkyl, C2-C6 haloalkenyl, haloalkynyl C2-C6 cycloalkyl, C3-C6 halocycloalkenyl Cs-C7, C5-C8 halocicloalquinilo alkoxy C? ~ C4 haloalkoxy C? -C4, C1-C4 alkylthio, haloalkylthio C? ~ C4, C1-C4 alkylsulfinyl, alkylsulfonyl C1- C4, Ci-C4 alkylamino, C2-C4 dialkylamino, C3-C6 cycloalkylamino, alkyl C? C6-cycloalkylamino C3-C6 alkylcarbonyl, C2-C4 alkoxycarbonyl C2-Cd, alkylaminocarbonyl C2-C6 dialkylaminocarbonyl C3-Css, alkoxycarbonyloxy C2-C6 alkylaminocarbonyloxy C2-C6 alkylaminocarbonyloxy C3-C6 trialkylsilyl C3-C6 or phenyl, where it is possible that the phenyl group is in turn substituted by hydroxy, C? -C6 alkyl, C? -C6 haloalkyl, C? -C6 alkylthio, Ci-Ce haloalkylthio, C3-C6 alkenylthio, C3-C6 haloalkenylthio, C3-C6 alkynylthio, C1-C3alkoxy-C1-C3alkylthio, C2-C4alkylcarbonyl-C1-C3alkylthio, C2-C4alkoxycarbaryl-C3-C3alkyl, cyano-C1-C3alkynyl, Cs-C6alkylsulfinyl, haloalkylsulfinyl Ci-Ce, C 1 -C 9 alkylsulfonyl, Ci-Cß haloalkylsulfonyl, aminosulfonyl, C 1 -C 2 alkylaminosulfonyl, N, N-di (C 2 -C 4 alkyl) aminosulfonyl, di (C 1 -C 4 alkyl) amino, halogen, cyano or nitro; and wherein the substituents on the nitrogen atoms in the ring systems are other than halogen; each Ri independently is halogen, nitro, cyano, hydroxy, C? -C6 alkyl, C2-C6 alkenyl, C2-C6 alkyl, C3-C6 cycloalkyl, Ci-Ce haloalkyl, C2-C6 haloalkenyl, C2-C6 haloalkynyl, C3 halocycloalkyl C6, C1-C4 alkoxy, C1-C4 haloalkoxy, C1-C4 alkylthio, haloalkylthio C1-C4, haloalquilsulfmilo C1-C4 haloalkylsulfonyl C1-C4 alkyl, alquilsulfmilo C1-C4 alkyl, C1-C4, alquilammo C? ~ C4, dialquilammo C2-C4, cicloalquilammo C3-C6 alkyl, C? C6-cicloalquilammo C3-C6 alkylcarbonyl, C2-C4 alkoxycarbonyl C2-C6 alkyl, alquilammocarbomlo C2-C6 alkyl, dialquilammocarbomlo C3-C ?, alkoxycarbonyloxy C2-C6, alquilammocarboniloxi C2-SCs , C3-C6 dialkylammocarbonyloxy or C3-C6 trialkylsilyl, phenyl, benzyl or phenoxy, or phenyl, benzyl or phenoxy mono-, di- or trisubstituted with halogen, cyano, nitro, halogen, Ci-Cß alkyl, C2-C6 alkenyl, alkyl C2-C6, C3-C6 cycloalkyl, C6-C6 haloalkyl, C2-C6 haloalkenyl, C2-C6 haloalkyl, C3-C6 haloalkyl, C1-C4 alkoxy, haloalkoxy C1- C4, C 1 -C 4 alkylthio, C 1 -C 4 haloalkylthio, C 1 -C 4 alkylsulfonyl, C 1 -C 4 alkylsulfonyl, C 1 -C 4 alkylamino, C 2 -C 4 dialkylamino, C 3 -C 6 cycloalkylamino, C 1 -C 6 alkyl- c ?cloalkyl ?mom C3- C6, C2-C4 alkylcarbonyl, C2-C6 alkoxycarbonyl, C2-C6 alkylaminocarbonyl, C3-C6 dialquilammocarbonilo, C2-C6 alkoxycarbonyloxy, alquilammocarboniloxi C2-C6, C3-C6 dialquilammocarboniloxi or C3-C6 trialkylsilyl; or n is O, 1, 2 or 3; each of R2 and R3, which may be the same or different, represent hydrogen, Ci-Ce alkyl, C2-C6 alkenyl, C2-C6 alkynyl or C3-C8 cycloalkyl; or C? -C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl or C3-C8 cycloalkyl substituted with one or more substituents selected from halogen, nitro, cyano, hydroxy, C? -C alkoxy, CX-C4 haloalkoxy, alkylthio C C 4, C 1 -C 4 haloalkylthio, Ci-C alkylsulfinyl, C 1 -C 4 alkylsulfonyl, C 1 -C 4 alkylamino, C 2 -C 4 dialkylamino, C 3 -C 6 cycloalkylamino, and C 1 -C 6 -cycloalkylamino C 3 -C 6 alkyl; D is phenyl, 2-pyridyl, 3-pyridyl or 4-pyridyl; or phenyl, 2-pyridyl, 3-pyridyl or 4-pyridyl mono-, di- or trisubstituted with C 1 -C 4 alkyl, C 3 -C 6 cycloalkyl C 1 -C 6 haloalkyl, halogen, cyano, C 1 -C 4 alkoxy, C 1 -C 4 haloalkoxy , C 1 -C 4 alkylthio, C 1 -C 4 haloalkylthio, C 1 -C 4 alkylsulfinyl, C 1 -C 4 alkylsulfonyl, C 1 -C 4 haloalkylsulfinyl or C 1 -C 4 haloalkylsulfonyl, or D is a group (Dß). R4, R4 ', Rio, R7 and R19 independently of each other, are hydrogen, C6-C6 alkyl, C3-C6 cycloalkyl, Ci-Cd haloalkyl, halogen, cyano, C?-C4 alkoxy, C?-C4 haloalkoxy alkoxy, C2-C4, alkylthio C ~ C4 ~ C4 haloalkylthio C, C ~ C4 alkylsulfinyl, alkylsulfonyl C -C4 haloalkylsulfinyl, haloalkylsulfonyl or C ~ C ~ C4 C4?????; R5, R6, R8, Rn, R? 2, R15, Rie and IIe independently of each other, are C? -C6 alkyl, or C? Alkyl? mono-, di- or trisubstituted by halogen, cyano, nitro, hydroxy, C? -C alkoxy, C2-C4, C1-C4 alkylthio, C1-C4 alkylsulfinyl, C1-C4 alkylsulfonyl, C1-C4 alkylamino, dialkylamino C2- C4 or C3-C6 cycloalkylamino; or are phenyl, 2-pyridyl, 3-pyridyl or 4-pyridyl; or are phenyl, 2-pyridyl, 3-pyridyl or 4-pyridyl mono-, di- or trisubstituted with C? C6 alkyl, C3-C6 haloalkyl C? C6 alkyl, halogen, cyano, C1-C4 alkoxy, haloC ? C4 alkyl, C1-C4 alkylthio, C1-C4 haloalkylthio, C1-C4 alkylsulfinyl, C1-C4 haloalkylsulfinyl, C1-C4 haloalkylsulfonyl or C1-C4, R7, R9, R13 and R14 independently are hydrogen, C ? -C6 haloalkyl C? C6 alkyl, C2-C6 alkenyl, C2-C6 haloalkenyl, C3-C6 alkenyl or C3-C6 haloalkenyl and salts / isomers / enantiomers / tautomers / N-oxides agronomically acceptable such compounds. 2. Compound according to claim 1, characterized in that R4 'is hydrogen. 3. Pesticidal composition, characterized in that it comprises at least one compound according to claim 1, of formula I or, where appropriate, a tautomer thereof, in each case in free form or in an agronomically usable salt form, as Active ingredient and at least one auxiliary. 4. Composition according to claim 3, characterized in that it is for controlling insects or representatives of the Acariña order. Method for controlling pests, characterized in that it comprises applying a composition according to claim 3, to the pests or to their environment. Method according to claim 5, characterized in that it is for controlling insects or representatives of the Acariña order. Method according to claim 5, characterized in that it is for the protection of a propagation material of plants, against the attack of pests, which comprises treating the propagation material or the site where the propagation material is planted. 8. Plant propagation material, characterized in that it was treated in accordance with claim 7. 9. Process for the preparation of a compound of formula I according to claim 1, or when appropriate, a tautomer thereof, in each case in free form or salt form, characterized in that it comprises a) for the preparation of a compound of formula I, wherein R 2 is hydrogen and E and Z are oxygen, or, where appropriate, a tautomer and / or a salt of the more, react a compound of the formula wherein Ri, n and D have the meanings indicated for the formula I, or when appropriate, a tautomer and / or a salt thereof with a compound of the formula HN (R3) - (A) q- (X) p-Y-B III wherein R3, p, q, A, X, Y and B have the meanings indicated for formula I, or when appropriate, a tautomer and / or a salt thereof or, b) to prepare a compound of formula I or , when appropriate, a tautomer and / or a salt thereof, reacting a compound of the formula wherein Ri, R2, n, Z and D have the meanings indicated for formula I; and X x is a leaving group or when appropriate, a tautomer and / or a salt thereof with a compound of the formula HN (R3) - (A); ? ) P-? - III wherein R3, p, q, A, X, Y and B have the meanings indicated for formula I, or when appropriate with a tautomer and / or a salt thereof or, c) to prepare a compound of formula I or when a tautomer and / or a salt thereof is appropriate, reacting a compound of the formula wherein Ri, R2, R3, n, p, q, A, X, Y, Z and B have the meanings indicated for formula I, or when appropriate, a tautomer and / or a salt thereof with a compound of the formula X2C (= 0) D (vi; where Ri has the meaning indicated for formula I; and X2 is a leaving group, or when appropriate, with a tautomer and / or a salt thereof. 10. Formula compound characterized in that Ri, R2, R3, n, p, q, A, X, Y, Z and B have the meanings indicated for formula I in claim 1. 11. Compound according to claim 10, characterized in that Ri is C 1 -C 4 alkyl, halogen, C 1 -C 5 haloalkyl, nitro, C 1 -C 4 alkoxy, C 1 -C 4 haloalkoxy, C 1 -C 4 alkylthio, C 1 -C 4 alkylsulfinyl, C 1 -C 4 alkylsulfonyl, C 1 -C 4 haloalkylthio, C 1 -C 4 haloalkylsulfinyl or haloalkylsulfonyl C? -C4; R2 and R3 are hydrogen; A is C? -C6 alkylene which may be substituted with C3-C6 cycloalkyl, C2-C6 alkenyl, cyano, C1-C4 alkylthio, C1-C4 alkylsulfonyl, C1-C4 alkoxy, halogen or Ci-Ce haloalkyl, "or A is C3-C6 cycloalkylene: p and q are, independently of each other, 0 or 1, X is oxygen, NH, NCH3 or NC2H5, Y is C?-C4 alkylene, C2-Cd alkenylene or C3-C6 alkynylene or C al-C4 alkylene , C2-C6 alkenylene or C3-C6 alkynylene substituted with halogen, C3-C6 cycloalkyl, C1-C4 alkylsulfonyl or C? -C alkoxy; and B is cyclopropyl or cyclobutyl which may be mono-di-, or trisubstituted with halogen, alkyl C 1 -C 4, hydroxy, cyano, C 1 -C 4 alkoxy or C 1 -C 4 alkylthio, or B is CH (CH 20), CH (CHMeO), CH- (CMe 20), CH (CH 2 S), CH (CH 2 CH 2), CH ( CHMeOCH2), CH (CMe20CH2), CH (CH2S- (0) 2CH2), CH (CHMeS (0) 2CH2), CH (CMe2S (O) 2CH2), C (Me) - (CH20), C (Me) (CHMeO), C (Me) - (CMe20), C (Me) - (CH2S), C (Me) - (CH2OCH2), C (Me) (CHMeOCH2), C (Me) - (CMe2OCH2), C (Me) - (CH2S (O) 2CH2), C (Me) - (CHMe-S (0) 2CH2) or C (Me) - (CMe2-S (O) 2CH2). Compound according to claim 11, characterized in that B is cyclopropyl or cyclobutyl which may be mono-, di- or t-substituted by halogen, C 1 -C 4 alkyl, hydroxy, cyano, C 1 -C 4 alkoxy or C 1 -C 4 alkylthio. 13. Formula compound characterized in that Ri, n and D have the meanings indicated for formula I in claim 1.